Bryan S. Graham - Publications

Affiliations: 
Economics University of California, Berkeley, Berkeley, CA 

474 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Corbett KS, Gagne M, Wagner DA, Connell SO, Narpala SR, Flebbe DR, Andrew SF, Davis RL, Flynn B, Johnston TS, Stringham C, Lai L, Valentin D, Van Ry A, Flinchbaugh Z, ... Graham BS, et al. Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates. Biorxiv : the Preprint Server For Biology. PMID 34426813 DOI: 10.1101/2021.08.11.456015  1
2021 Corbett KS, Werner AP, Connell SO, Gagne M, Lai L, Moliva JI, Flynn B, Choi A, Koch M, Foulds KE, Andrew SF, Flebbe DR, Lamb E, Nurmukhambetova ST, Provost SJ, ... Graham BS, et al. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates. Nature Immunology. PMID 34417590 DOI: 10.1038/s41590-021-01021-0  1
2021 Pegu A, O'Connell S, Schmidt SD, O'Dell S, Talana CA, Lai L, Albert J, Anderson E, Bennett H, Corbett KS, Flach B, Jackson L, Leav B, Ledgerwood JE, Luke CJ, ... Graham BS, et al. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science (New York, N.Y.). PMID 34385356 DOI: 10.1126/science.abj4176  1
2021 Bok K, Sitar S, Graham BS, Mascola JR. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects. Immunity. 54: 1636-1651. PMID 34348117 DOI: 10.1016/j.immuni.2021.07.017  1
2021 Francica JR, Flynn BJ, Foulds KE, Noe AT, Werner AP, Moore IN, Gagne M, Johnston TS, Tucker C, Davis RL, Flach B, O'Connell S, Andrew SF, Lamb E, Flebbe DR, ... Graham BS, et al. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates. Science Translational Medicine. PMID 34315825 DOI: 10.1126/scitranslmed.abi4547  1
2021 DiPiazza AT, Leist SR, Abiona OM, Moliva JI, Werner A, Minai M, Nagata BM, Bock KW, Phung E, Schäfer A, Dinnon KH, Chang LA, Loomis RJ, Boyoglu-Barnum S, Alvarado GS, ... Graham BS, et al. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge. Immunity. PMID 34270939 DOI: 10.1016/j.immuni.2021.06.018  1
2021 Li D, Edwards RJ, Manne K, Martinez DR, Schäfer A, Alam SM, Wiehe K, Lu X, Parks R, Sutherland LL, Oguin TH, McDanal C, Perez LG, Mansouri K, Gobeil SMC, ... Graham BS, et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. PMID 34242577 DOI: 10.1016/j.cell.2021.06.021  1
2021 Wang L, Zhou T, Zhang Y, Yang ES, Schramm CA, Shi W, Pegu A, Oloniniyi OK, Henry AR, Darko S, Narpala SR, Hatcher C, Martinez DR, Tsybovsky Y, Phung E, ... Graham BS, et al. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants. Science (New York, N.Y.). PMID 34210892 DOI: 10.1126/science.abh1766  1
2021 Chuang GY, Shen CH, Cheung CS, Gorman J, Creanga A, Joyce MG, Leung K, Rawi R, Wang L, Yang ES, Yang Y, Zhang B, Zhang Y, Kanekiyo M, Zhou T, ... Graham BS, et al. Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses. Frontiers in Immunology. 12: 662909. PMID 34135892 DOI: 10.3389/fimmu.2021.662909  1
2021 Garrido C, Curtis AD, Dennis M, Pathak SH, Gao H, Montefiori D, Tomai M, Fox CB, Kozlowski PA, Scobey T, Munt JE, Mallory ML, Saha PT, Hudgens MG, Lindesmith LC, ... ... Graham B, et al. SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques. Science Immunology. 6. PMID 34131024 DOI: 10.1126/sciimmunol.abj3684  1
2021 Taleb SA, Al-Ansari K, Nasrallah GK, Elrayess MA, Al-Thani AA, Derrien-Colemyn A, Ruckwardt TJ, Graham BS, Yassine HM. Level of Maternal Respiratory Syncytial Virus (RSV) F Antibodies in Hospitalized Children and Correlates of Protection. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 34118428 DOI: 10.1016/j.ijid.2021.06.015  1
2021 Corbett KS, Werner AP, O' Connell S, Gagne M, Lai L, Moliva JI, Flynn B, Choi A, Koch M, Foulds KE, Andrew SF, Flebbe DR, Lamb E, Nurmukhambetova ST, Provost SJ, ... Graham BS, et al. Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates. Biorxiv : the Preprint Server For Biology. PMID 34075375 DOI: 10.1101/2021.05.21.445189  1
2021 Shiakolas AR, Kramer KJ, Wrapp D, Richardson SI, Schäfer A, Wall S, Wang N, Janowska K, Pilewski KA, Venkat R, Parks R, Manamela NP, Raju N, Fechter EF, Holt CM, ... Graham BS, et al. Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions. Cell Reports. Medicine. 100313. PMID 34056628 DOI: 10.1016/j.xcrm.2021.100313  1
2021 Pegu A, O'Connell S, Schmidt SD, O'Dell S, Talana CA, Lai L, Albert J, Anderson E, Bennett H, Corbett KS, Flach B, Jackson L, Leav B, Ledgerwood JE, Luke CJ, ... Graham BS, et al. Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants. Biorxiv : the Preprint Server For Biology. PMID 34031659 DOI: 10.1101/2021.05.13.444010  1
2021 Salimi V, Viegas M, Trento A, Agoti CN, Anderson LJ, Avadhanula V, Bahl J, Bont L, Brister JR, Cane PA, Galiano M, Graham BS, Hatcher EL, Hellferscee O, Henke DM, et al. Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level. Emerging Infectious Diseases. 27: 1-9. PMID 34013862 DOI: 10.3201/eid2706.204608  1
2021 McFarland EJ, Cunningham CK, Muresan P, Capparelli EV, Perlowski C, Morgan P, Smith B, Hazra R, Purdue L, Harding PA, Theron G, Mujuru H, Agwu A, Purswani M, Rathore MH, ... Graham BS, et al. Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants. The Journal of Infectious Diseases. PMID 34009371 DOI: 10.1093/infdis/jiab229  1
2021 Westendorf K, Žentelis S, Foster D, Vaillancourt P, Wiggin M, Lovett E, Hendle J, Pustilnik A, Sauder JM, Kraft L, Hwang Y, Siegel RW, Chen J, Heinz BA, Higgs RE, ... Graham BS, et al. LY-CoV1404 potently neutralizes SARS-CoV-2 variants. Biorxiv : the Preprint Server For Biology. PMID 33972947 DOI: 10.1101/2021.04.30.442182  1
2021 Burgomaster KE, Foreman BM, Aleshnick MA, Larman BC, Gordon DN, Maciejewski S, Morabito KM, Ledgerwood JE, Gaudinski MR, Chen GL, Mascola JR, Debbink K, Dowd KA, Graham BS, Pierson TC. Limited flavivirus cross-reactive antibody responses elicited by a ZIKV DNA vaccine candidate in humans. The Journal of Infectious Diseases. PMID 33961055 DOI: 10.1093/infdis/jiab185  1
2021 Martinez DR, Schaefer A, Gobeil S, Li D, De la Cruz G, Parks R, Lu X, Barr M, Manne K, Mansouri K, Edwards RJ, Yount B, Anasti K, Montgomery SA, Shen S, ... Graham BS, et al. A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice. Biorxiv : the Preprint Server For Biology. PMID 33948590 DOI: 10.1101/2021.04.27.441655  1
2021 Corbett KS, Nason MC, Flach B, Gagne M, O' Connell S, Johnston TS, Shah SN, Edara VV, Floyd K, Lai L, McDanal C, Francica JR, Flynn B, Wu K, Choi A, ... Graham BS, et al. Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates. Biorxiv : the Preprint Server For Biology. PMID 33907752 DOI: 10.1101/2021.04.20.440647  1
2021 Wu K, Choi A, Koch M, Elbashir S, Ma L, Lee D, Woods A, Henry C, Palandjian C, Hill A, Quinones J, Nunna N, O'Connell S, McDermott AB, Falcone S, ... Graham BS, et al. Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice. Biorxiv : the Preprint Server For Biology. PMID 33880468 DOI: 10.1101/2021.04.13.439482  1
2021 Ruckwardt TJ, Morabito KM, Phung E, Crank MC, Costner PJ, Holman LA, Chang LA, Hickman SP, Berkowitz NM, Gordon IJ, Yamshchikov GV, Gaudinski MR, Lin B, Bailer R, Chen M, ... Graham BS, et al. Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial. The Lancet. Respiratory Medicine. PMID 33864736 DOI: 10.1016/S2213-2600(21)00098-9  1
2021 Garrido C, Curtis AD, Dennis M, Pathak SH, Gao H, Montefiori D, Tomai M, Fox CB, Kozlowski PA, Scobey T, Munt JE, Mallroy ML, Saha PT, Hudgens MG, Lindesmith LC, ... ... Graham B, et al. SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus Macaques. Biorxiv : the Preprint Server For Biology. PMID 33851156 DOI: 10.1101/2021.04.05.438479  1
2021 Mukhamedova M, Wrapp D, Shen CH, Gilman MSA, Ruckwardt TJ, Schramm CA, Ault L, Chang L, Derrien-Colemyn A, Lucas SAM, Ransier A, Darko S, Phung E, Wang L, Zhang Y, ... Graham BS, et al. Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses. Immunity. PMID 33823129 DOI: 10.1016/j.immuni.2021.03.004  1
2021 Doria-Rose N, Suthar MS, Makowski M, O'Connell S, McDermott AB, Flach B, Ledgerwood JE, Mascola JR, Graham BS, Lin BC, O'Dell S, Schmidt SD, Widge AT, Edara VV, Anderson EJ, et al. Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19. The New England Journal of Medicine. PMID 33822494 DOI: 10.1056/NEJMc2103916  1
2021 Jones BE, Brown-Augsburger PL, Corbett KS, Westendorf K, Davies J, Cujec TP, Wiethoff CM, Blackbourne JL, Heinz BA, Foster D, Higgs RE, Balasubramaniam D, Wang L, Zhang Y, Yang ES, ... Graham BS, et al. The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in non-human primates. Science Translational Medicine. PMID 33820835 DOI: 10.1126/scitranslmed.abf1906  1
2021 Boyoglu-Barnum S, Ellis D, Gillespie RA, Hutchinson GB, Park YJ, Moin SM, Acton OJ, Ravichandran R, Murphy M, Pettie D, Matheson N, Carter L, Creanga A, Watson MJ, Kephart S, ... Graham BS, et al. Quadrivalent influenza nanoparticle vaccines induce broad protection. Nature. PMID 33762730 DOI: 10.1038/s41586-021-03365-x  1
2021 Creanga A, Gillespie RA, Fisher BE, Andrews SF, Lederhofer J, Yap C, Hatch L, Stephens T, Tsybovsky Y, Crank MC, Ledgerwood JE, McDermott AB, Mascola JR, Graham BS, Kanekiyo M. A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies. Nature Communications. 12: 1722. PMID 33741916 DOI: 10.1038/s41467-021-21954-2  1
2021 Fahad AS, Timm MR, Madan B, Burgomaster KE, Dowd KA, Normandin E, Gutiérrez-González MF, Pennington JM, De Souza MO, Henry AR, Laboune F, Wang L, Ambrozak DR, Gordon IJ, Douek DC, ... Graham BS, et al. Functional Profiling of Antibody Immune Repertoires in Convalescent Zika Virus Disease Patients. Frontiers in Immunology. 12: 615102. PMID 33732238 DOI: 10.3389/fimmu.2021.615102  1
2021 Hicks J, Klumpp-Thomas C, Kalish H, Shunmugavel A, Mehalko J, Denson JP, Snead KR, Drew M, Corbett KS, Graham BS, Hall MD, Memoli MJ, Esposito D, Sadtler K. Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses. Journal of Clinical Immunology. PMID 33725211 DOI: 10.1007/s10875-021-00997-6  1
2021 Francica JR, Flynn BJ, Foulds KE, Noe AT, Werner AP, Moore IN, Gagne M, Johnston TS, Tucker C, Davis RL, Flach B, O'Connell S, Andrew SF, Lamb E, Flebbe DR, ... Graham BS, et al. Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates. Biorxiv : the Preprint Server For Biology. PMID 33688652 DOI: 10.1101/2021.03.02.433390  1
2021 Wang P, Nair MS, Liu L, Iketani S, Luo Y, Guo Y, Wang M, Yu J, Zhang B, Kwong PD, Graham BS, Mascola JR, Chang JY, Yin MT, Sobieszczyk M, et al. Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7. Nature. PMID 33684923 DOI: 10.1038/s41586-021-03398-2  1
2021 Darricarrère N, Qiu Y, Kanekiyo M, Creanga A, Gillespie RA, Moin SM, Saleh J, Sancho J, Chou TH, Zhou Y, Zhang R, Dai S, Moody A, Saunders KO, Crank MC, ... Graham BS, et al. Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates. Science Translational Medicine. 13. PMID 33658355 DOI: 10.1126/scitranslmed.abe5449  1
2021 Wang L, Zhou T, Zhang Y, Yang ES, Schramm CA, Shi W, Pegu A, Oloninyi OK, Ransier A, Darko S, Narpala SR, Hatcher C, Martinez DR, Tsybovsky Y, Phung E, ... Graham BS, et al. Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants. Biorxiv : the Preprint Server For Biology. PMID 33655252 DOI: 10.1101/2021.02.25.432969  1
2021 Wu K, Werner AP, Koch M, Choi A, Narayanan E, Stewart-Jones GBE, Colpitts T, Bennett H, Boyoglu-Barnum S, Shi W, Moliva JI, Sullivan NJ, Graham BS, Carfi A, Corbett KS, et al. Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine - Preliminary Report. The New England Journal of Medicine. PMID 33596346 DOI: 10.1056/NEJMc2102179  1
2021 Mascola JR, Graham BS, Fauci AS. SARS-CoV-2 Viral Variants-Tackling a Moving Target. Jama. PMID 33571363 DOI: 10.1001/jama.2021.2088  1
2021 Wang P, Liu L, Iketani S, Luo Y, Guo Y, Wang M, Yu J, Zhang B, Kwong PD, Graham BS, Mascola JR, Chang JY, Yin MT, Sobieszczyk M, Kyratsous CA, et al. Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization. Biorxiv : the Preprint Server For Biology. PMID 33532778 DOI: 10.1101/2021.01.25.428137  1
2021 Wu K, Werner AP, Moliva JI, Koch M, Choi A, Stewart-Jones GBE, Bennett H, Boyoglu-Barnum S, Shi W, Graham BS, Carfi A, Corbett KS, Seder RA, Edwards DK. mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants. Biorxiv : the Preprint Server For Biology. PMID 33501442 DOI: 10.1101/2021.01.25.427948  1
2021 Yang Y, Shi W, Abiona OM, Nazzari A, Olia AS, Ou L, Phung E, Stephens T, Tsybovsky Y, Verardi R, Wang S, Werner A, Yap C, Ambrozak D, Bylund T, ... Graham BS, et al. Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses. Vaccines. 9. PMID 33494381 DOI: 10.3390/vaccines9020073  1
2021 Li D, Edwards RJ, Manne K, Martinez DR, Schäfer A, Alam SM, Wiehe K, Lu X, Parks R, Sutherland LL, Oguin TH, McDanal C, Perez LG, Mansouri K, Gobeil SMC, ... Graham BS, et al. The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates. Biorxiv : the Preprint Server For Biology. PMID 33442694 DOI: 10.1101/2020.12.31.424729  1
2020 Shiakolas AR, Kramer KJ, Wrapp D, Richardson SI, Schäfer A, Wall S, Wang N, Janowska K, Pilewski KA, Venkat R, Parks R, Manamela NP, Raju N, Fechter EF, Holt CM, ... Graham BS, et al. Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions. Biorxiv : the Preprint Server For Biology. PMID 33398266 DOI: 10.1101/2020.12.20.414748  1
2020 Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Kehtan S, Segall N, Solis J, Brosz A, ... Graham BS, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. The New England Journal of Medicine. PMID 33378609 DOI: 10.1056/NEJMoa2035389  1
2020 Widge AT, Rouphael NG, Jackson LA, Anderson EJ, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott AB, Flach B, Lin BC, Doria-Rose NA, O'Dell S, ... Graham BS, et al. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. The New England Journal of Medicine. PMID 33270381 DOI: 10.1056/NEJMc2032195  1
2020 DiPiazza AT, Graham BS, Ruckwardt TJ. T cell immunity to SARS-CoV-2 following natural infection and vaccination. Biochemical and Biophysical Research Communications. PMID 33190827 DOI: 10.1016/j.bbrc.2020.10.060  1
2020 Zhang B, Chao CW, Tsybovsky Y, Abiona OM, Hutchinson GB, Moliva JI, Olia AS, Pegu A, Phung E, Stewart-Jones GBE, Verardi R, Wang L, Wang S, Werner A, Yang ES, ... Graham BS, et al. A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone. Scientific Reports. 10: 18149. PMID 33097791 DOI: 10.1038/s41598-020-74949-2  1
2020 Zhou T, Teng IT, Olia AS, Cerutti G, Gorman J, Nazzari A, Shi W, Tsybovsky Y, Wang L, Wang S, Zhang B, Zhang Y, Katsamba PS, Petrova Y, Banach BB, ... Graham BS, et al. Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes. Cell Reports. 108322. PMID 33091382 DOI: 10.1016/j.celrep.2020.108322  1
2020 Jones BE, Brown-Augsburger PL, Corbett KS, Westendorf K, Davies J, Cujec TP, Wiethoff CM, Blackbourne JL, Heinz BA, Foster D, Higgs RE, Balasubramaniam D, Wang L, Bidshahri R, Kraft L, ... Graham BS, et al. LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection. Biorxiv : the Preprint Server For Biology. PMID 33024963 DOI: 10.1101/2020.09.30.318972  1
2020 Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott AB, Flach B, Lin BC, Doria-Rose NA, O'Dell S, ... Graham BS, et al. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults. The New England Journal of Medicine. PMID 32991794 DOI: 10.1056/NEJMoa2028436  1
2020 Li J, Nikanjam M, Cunningham CK, McFarland EJ, Coates EE, Houser KV, Lin BC, McDermott AB, Flach B, Gama L, Koup RA, Graham BS, Mascola JR, Ledgerwood JE, Capparelli EV. Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach. Clinical Pharmacology and Therapeutics. PMID 32866318 DOI: 10.1002/Cpt.2026  1
2020 Luisi K, Morabito KM, Burgomaster KE, Sharma M, Kong WP, Foreman BM, Patel S, Fisher B, Aleshnick MA, Laliberte J, Wallace M, Ruckwardt TJ, Gordon DN, Linton C, Ruggiero N, ... Graham BS, et al. Development of a potent Zika virus vaccine using self-amplifying messenger RNA. Science Advances. 6: eaba5068. PMID 32821824 DOI: 10.1126/Sciadv.Aba5068  1
2020 Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, Himansu S, Schäfer A, Ziwawo CT, DiPiazza AT, Dinnon KH, Elbashir SM, Shaw CA, Woods A, Fritch EJ, ... Graham BS, et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. PMID 32756549 DOI: 10.1038/S41586-020-2622-0  1
2020 Ueda G, Antanasijevic A, Fallas JA, Sheffler W, Copps J, Ellis D, Hutchinson GB, Moyer A, Yasmeen A, Tsybovsky Y, Park YJ, Bick MJ, Sankaran B, Gillespie RA, Brouwer PJ, ... Graham BS, et al. Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens. Elife. 9. PMID 32748788 DOI: 10.7554/Elife.57659  1
2020 Zhou T, Teng IT, Olia AS, Cerutti G, Gorman J, Nazzari A, Shi W, Tsybovsky Y, Wang L, Wang S, Zhang B, Zhang Y, Katsamba PS, Petrova Y, Banach BB, ... Graham BS, et al. Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes. Ssrn. 3639618. PMID 32742241 DOI: 10.2139/ssrn.3639618  1
2020 Corbett KS, Flynn B, Foulds KE, Francica JR, Boyoglu-Barnum S, Werner AP, Flach B, O'Connell S, Bock KW, Minai M, Nagata BM, Andersen H, Martinez DR, Noe AT, Douek N, ... Graham BS, et al. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates. The New England Journal of Medicine. PMID 32722908 DOI: 10.1056/Nejmoa2024671  1
2020 Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, ... Graham BS, et al. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. The New England Journal of Medicine. PMID 32663912 DOI: 10.1056/Nejmoa2022483  1
2020 Hallowell BD, Carlson CM, Jacobs JR, Pomeroy M, Steinberg J, Tenforde M, McDonald E, Foster L, Feldstein LR, Rolfes MA, Haynes A, Abedi GR, Odongo GS, Saruwatari K, Rider EC, ... Graham BS, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure Among Evacuees from Wuhan, China, 2020. Emerging Infectious Diseases. 26. PMID 32620182 DOI: 10.3201/Eid2609.201590  1
2020 Zhou T, Teng IT, Olia AS, Cerutti G, Gorman J, Nazzari A, Shi W, Tsybovsky Y, Wang L, Wang S, Zhang B, Zhang Y, Katsamba PS, Petrova Y, Banach BB, ... Graham BS, et al. Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes. Biorxiv : the Preprint Server For Biology. PMID 32596696 DOI: 10.1101/2020.06.22.166033  1
2020 Loomis RJ, Stewart-Jones GBE, Tsybovsky Y, Caringal RT, Morabito KM, McLellan JS, Chamberlain AL, Nugent ST, Hutchinson GB, Kueltzo LA, Mascola JR, Graham BS. Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development. Frontiers in Immunology. 11: 842. PMID 32595632 DOI: 10.3389/Fimmu.2020.00842  1
2020 Corbett KS, Edwards D, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, Himansu S, Schäfer A, Ziwawo CT, DiPiazza AT, Dinnon KH, Elbashir SM, Shaw CA, Woods A, Fritch EJ, ... Graham BS, et al. SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness. Biorxiv : the Preprint Server For Biology. PMID 32577634 DOI: 10.1101/2020.06.11.145920  1
2020 Wec AZ, Wrapp D, Herbert AS, Maurer DP, Haslwanter D, Sakharkar M, Jangra RK, Dieterle ME, Lilov A, Huang D, Tse LV, Johnson NV, Hsieh CL, Wang N, Nett JH, ... Graham BS, et al. Broad neutralization of SARS-related viruses by human monoclonal antibodies. Science (New York, N.Y.). PMID 32540900 DOI: 10.1126/Science.Abc7424  1
2020 Wrapp D, De Vlieger D, Corbett KS, Torres GM, Wang N, Van Breedam W, Roose K, van Schie L, Hoffmann M, Pöhlmann S, Graham BS, Callewaert N, Schepens B, Saelens X, et al. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies. Cell. 181: 1436-1441. PMID 32531248 DOI: 10.1016/J.Cell.2020.05.047  1
2020 Maciejewski S, Ruckwardt TJ, Morabito KM, Foreman BM, Burgomaster KE, Gordon DN, Pelc RS, DeMaso CR, Ko SY, Fisher BE, Yang ES, Nair D, Foulds KE, Todd JP, Kong WP, ... Graham BS, et al. Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality. Science Translational Medicine. 12. PMID 32522807 DOI: 10.1126/Scitranslmed.Aaw9066  1
2020 Wec AZ, Wrapp D, Herbert AS, Maurer D, Haslwanter D, Sakharkar M, Jangra RK, Dieterle ME, Lilov A, Huang D, Tse LV, Johnson NV, Hsieh CL, Wang N, Nett JH, ... Graham BS, et al. Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein. Biorxiv : the Preprint Server For Biology. PMID 32511337 DOI: 10.1101/2020.05.15.096511  1
2020 Freeman B, Lester S, Mills L, Rasheed MAU, Moye S, Abiona O, Hutchinson GB, Morales-Betoulle M, Krapinunaya I, Gibbons A, Chiang CF, Cannon D, Klena J, Johnson JA, Owen SM, Graham BS, et al. Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance. Biorxiv : the Preprint Server For Biology. PMID 32511332 DOI: 10.1101/2020.04.24.057323  1
2020 Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. Biorxiv : the Preprint Server For Biology. PMID 32511295 DOI: 10.1101/2020.02.11.944462  1
2020 Wei CJ, Crank MC, Shiver J, Graham BS, Mascola JR, Nabel GJ. Author Correction: Next-generation influenza vaccines: opportunities and challenges. Nature Reviews. Drug Discovery. 19: 427. PMID 32494049 DOI: 10.1038/S41573-020-0066-8  1
2020 Buchwald AG, Graham BS, Traore A, Haidara FC, Chen M, Morabito K, Lin BC, Sow SO, Levine MM, Pasetti MF, Tapia MD. RSV neutralizing antibodies at birth predict protection from RSV illness in infants in the first three months of life. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32463443 DOI: 10.1093/Cid/Ciaa648  1
2020 Choi JH, Woo HM, Lee TY, Lee SY, Shim SM, Park WJ, Yang JS, Kim JA, Yun MR, Kim DW, Kim SS, Zhang Y, Shi W, Wang L, Graham BS, et al. Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus. Plos One. 15: e0232757. PMID 32384116 DOI: 10.1371/Journal.Pone.0232757  1
2020 Wrapp D, De Vlieger D, Corbett KS, Torres GM, Wang N, Van Breedam W, Roose K, van Schie L, Hoffmann M, Pöhlmann S, Graham BS, Callewaert N, Schepens B, Saelens X, et al. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies. Cell. PMID 32375025 DOI: 10.1016/J.Cell.2020.04.031  1
2020 Graham BS, Corbett KS. Prototype pathogen approach for pandemic preparedness: world on fire. The Journal of Clinical Investigation. PMID 32352406 DOI: 10.1172/Jci139601  1
2020 Chen GL, Coates EE, Plummer SH, Carter CA, Berkowitz N, Conan-Cibotti M, Cox JH, Beck A, O'Callahan M, Andrews C, Gordon IJ, Larkin B, Lampley R, Kaltovich F, Gall J, ... Graham BS, et al. Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial. Jama. 323: 1369-1377. PMID 32286643 DOI: 10.1001/Jama.2020.2477  1
2020 Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (New York, N.Y.). PMID 32075877 DOI: 10.1126/Science.Abb2507  1
2020 Wei CJ, Crank MC, Shiver J, Graham BS, Mascola JR, Nabel GJ. Next-generation influenza vaccines: opportunities and challenges. Nature Reviews. Drug Discovery. PMID 32060419 DOI: 10.1038/S41573-019-0056-X  1
2020 Liu X, Liang B, Liu X, Amaro-Carambot E, Surman S, Kwong PD, Graham BS, Collins PL, Munir S. Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates. Plos One. 15: e0228572. PMID 32045432 DOI: 10.1371/Journal.Pone.0228572  1
2020 Boyoglu-Barnum S, Hutchinson GB, Boyington JC, Moin SM, Gillespie RA, Tsybovsky Y, Stephens T, Vaile JR, Lederhofer J, Corbett KS, Fisher BE, Yassine HM, Andrews SF, Crank MC, McDermott AB, ... Graham BS, et al. Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses. Nature Communications. 11: 791. PMID 32034141 DOI: 10.1038/S41467-020-14579-4  1
2020 Ueda G, Antanasijevic A, Fallas JA, Sheffler W, Copps J, Ellis D, Hutchinson GB, Moyer A, Yasmeen A, Tsybovsky Y, Park Y, Bick MJ, Sankaran B, Gillespie RA, Brouwer PJ, ... Graham BS, et al. Author response: Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens Elife. DOI: 10.7554/Elife.57659.Sa2  1
2019 Joyce MG, Bao A, Chen M, Georgiev IS, Ou L, Bylund T, Druz A, Kong WP, Peng D, Rundlet EJ, Van Galen JG, Wang S, Yang Y, Zhang B, Chuang GY, ... Graham BS, et al. Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B. Pathogens & Immunity. 4: 294-323. PMID 31893251 DOI: 10.20411/pai.v4i2.338  1
2019 Van Rompay KKA, Keesler RI, Ardeshir A, Watanabe J, Usachenko J, Singapuri A, Cruzen C, Bliss-Moreau E, Murphy AM, Yee JL, Webster H, Dennis M, Singh T, Heimsath H, Lemos D, ... Graham BS, et al. DNA vaccination before conception protects Zika virus-exposed pregnant macaques against prolonged viremia and improves fetal outcomes. Science Translational Medicine. 11. PMID 31852797 DOI: 10.1126/Scitranslmed.Aay2736  1
2019 Kallas EG, Grunenberg NA, Yu C, Manso B, Pantaleo G, Casapia M, Baden LR, Valencia J, Sobieszczyk M, Van Tieu H, Allen M, Hural J, Graham BS, Kublin J, Gilbert PB, et al. Antigenic competition in CD4 T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial. Science Translational Medicine. 11. PMID 31748227 DOI: 10.1126/Scitranslmed.Aaw1673  1
2019 Cunningham CK, McFarland EJ, Morrison RL, Capparelli EV, Safrit JT, Mofenson LM, Mathieson B, Valentine ME, Perlowski C, Smith B, Hazra R, Purdue L, Muresan P, Harding PA, Mbengeranwa T, ... Graham BS, et al. Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants. The Journal of Infectious Diseases. PMID 31681963 DOI: 10.1093/Infdis/Jiz532  1
2019 Neidich SD, Fong Y, Li SS, Geraghty DE, Williamson BD, Young WC, Goodman D, Seaton KE, Shen X, Sawant S, Zhang L, deCamp AC, Blette BS, Shao M, Yates NL, ... Graham BS, et al. Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk. The Journal of Clinical Investigation. PMID 31589165 DOI: 10.1172/Jci126391  1
2019 Wang N, Rosen O, Wang L, Turner HL, Stevens LJ, Corbett KS, Bowman CA, Pallesen J, Shi W, Zhang Y, Leung K, Kirchdoerfer RN, Becker MM, Denison MR, Chappell JD, ... Graham BS, et al. Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD. Cell Reports. 28: 3395-3405.e6. PMID 31553909 DOI: 10.1016/J.Celrep.2019.08.052  1
2019 Ruckwardt TJ, Morabito KM, Graham BS. Immunological Lessons from Respiratory Syncytial Virus Vaccine Development. Immunity. 51: 429-442. PMID 31533056 DOI: 10.1016/j.immuni.2019.08.007  1
2019 Carter C, Houser KV, Yamshchikov GV, Bellamy AR, May J, Enama ME, Sarwar U, Larkin B, Bailer RT, Koup R, Chen GL, Patel SM, Winokur P, Belshe R, Dekker CL, Graham BS, et al. Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial. Plos One. 14: e0222178. PMID 31532789 DOI: 10.1371/Journal.Pone.0222178  1
2019 Rudicell RS, Garinot M, Kanekiyo M, Kamp HD, Swanson K, Chou TH, Dai S, Bedel O, Simard D, Gillespie RA, Yang K, Reardon M, Avila LZ, Besev M, Dhal PK, ... Graham BS, et al. Comparison of adjuvants to optimize influenza neutralizing antibody responses. Vaccine. PMID 31493950 DOI: 10.1016/J.Vaccine.2019.08.030  1
2019 Gaudinski MR, Houser KV, Doria-Rose NA, Chen GL, Rothwell RSS, Berkowitz N, Costner P, Holman LA, Gordon IJ, Hendel CS, Kaltovich F, Conan-Cibotti M, Gomez Lorenzo M, Carter C, Sitar S, ... Graham BS, et al. Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial. The Lancet. Hiv. PMID 31473167 DOI: 10.1016/S2352-3018(19)30181-X  1
2019 DiPiazza AT, Hill JP, Graham BS, Ruckwardt TJ. OMIP-061: 20-Color Flow Cytometry Panel for High-Dimensional Characterization of Murine Antigen-Presenting Cells. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. PMID 31424632 DOI: 10.1002/Cyto.A.23880  1
2019 Crank MC, Ruckwardt TJ, Chen M, Morabito KM, Phung E, Costner PJ, Holman LA, Hickman SP, Berkowitz NM, Gordon IJ, Yamshchikov GV, Gaudinski MR, Kumar A, Chang LA, Moin SM, ... Graham BS, et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science (New York, N.Y.). 365: 505-509. PMID 31371616 DOI: 10.1126/science.aav9033  1
2019 Andrews SF, Chambers MJ, Schramm CA, Plyler J, Raab JE, Kanekiyo M, Gillespie RA, Ransier A, Darko S, Hu J, Chen X, Yassine HM, Boyington JC, Crank MC, Chen GL, ... Graham BS, et al. Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin. Immunity. PMID 31350180 DOI: 10.1016/J.Immuni.2019.06.024  1
2019 Jagger BW, Dowd KA, Chen RE, Desai P, Foreman B, Burgomaster KE, Himansu S, Kong WP, Graham BS, Pierson TC, Diamond MS. Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice. The Journal of Infectious Diseases. PMID 31260518 DOI: 10.1093/Infdis/Jiz338  1
2019 Crowell TA, Colby DJ, Pinyakorn S, Sacdalan C, Pagliuzza A, Intasan J, Benjapornpong K, Tangnaree K, Chomchey N, Kroon E, de Souza MS, Tovanabutra S, Rolland M, Eller MA, Paquin-Proulx D, ... Graham BS, et al. Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial. The Lancet. Hiv. PMID 31000477 DOI: 10.1016/S2352-3018(19)30053-0  1
2019 Kanekiyo M, Joyce MG, Gillespie RA, Gallagher JR, Andrews SF, Yassine HM, Wheatley AK, Fisher BE, Ambrozak DR, Creanga A, Leung K, Yang ES, Boyoglu-Barnum S, Georgiev IS, Tsybovsky Y, ... Graham BS, et al. Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses. Nature Immunology. PMID 30980067 DOI: 10.1038/S41590-019-0395-0  1
2019 Al Kahlout RA, Nasrallah GK, Farag EA, Wang L, Lattwein E, Müller MA, El Zowalaty ME, Al Romaihi HE, Graham BS, Al Thani AA, Yassine HM. Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar. Journal of Immunology Research. 2019: 1386740. PMID 30906787 DOI: 10.1155/2019/1386740  1
2019 Phung E, Chang LA, Morabito KM, Kanekiyo M, Chen M, Nair D, Kumar A, Chen GL, Ledgerwood JE, Graham BS, Ruckwardt TJ. Epitope-Specific Serological Assays for RSV: Conformation Matters. Vaccines. 7. PMID 30813394 DOI: 10.3390/vaccines7010023  1
2019 Corbett KS, Moin SM, Yassine HM, Cagigi A, Kanekiyo M, Boyoglu-Barnum S, Myers SI, Tsybovsky Y, Wheatley AK, Schramm CA, Gillespie RA, Shi W, Wang L, Zhang Y, Andrews SF, ... Graham BS, et al. Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages. Mbio. 10. PMID 30808695 DOI: 10.1128/Mbio.02810-18  1
2019 Sesterhenn F, Galloux M, Vollers SS, Csepregi L, Yang C, Descamps D, Bonet J, Friedensohn S, Gainza P, Corthésy P, Chen M, Rosset S, Rameix-Welti MA, Éléouët JF, Reddy ST, Graham BS, et al. Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen. Plos Biology. 17: e3000164. PMID 30789898 DOI: 10.1371/journal.pbio.3000164  1
2019 Kanekiyo M, Joyce MG, Gillespie RA, Gallagher JR, Andrews SF, Yassine HM, Wheatley AK, Fisher BE, Ambrozak DR, Creanga A, Leung K, Yang ES, Boyoglu-Barnum S, Georgiev IS, Tsybovsky Y, ... Graham BS, et al. Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses. Nature Immunology. PMID 30742080 DOI: 10.1038/S41590-018-0305-X  1
2019 Crank MC, Mascola JR, Graham BS. Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine. The Journal of Infectious Diseases. PMID 30715413 DOI: 10.1093/Infdis/Jiz043  1
2019 Graham BS, Gilman MSA, McLellan JS. Structure-Based Vaccine Antigen Design. Annual Review of Medicine. 70: 91-104. PMID 30691364 DOI: 10.1146/Annurev-Med-121217-094234  1
2019 Gaudinski MR, Coates EE, Novik L, Widge A, Houser KV, Burch E, Holman LA, Gordon IJ, Chen GL, Carter C, Nason M, Sitar S, Yamshchikov G, Berkowitz N, Andrews C, ... Graham BS, et al. Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study. Lancet (London, England). PMID 30686586 DOI: 10.1016/S0140-6736(19)30036-4  1
2018 Yamamoto T, Masuta Y, Momota M, Kanekiyo M, Kanuma T, Takahama S, Moriishi E, Yasutomi Y, Saito T, Graham BS, Takahashi Y, Ishii KJ. A unique nanoparticulate TLR9 agonist enables a HA split vaccine to confer FcγR-mediated protection against heterologous lethal influenza virus infection. International Immunology. PMID 30535055 DOI: 10.1093/Intimm/Dxy069  1
2018 Kirchdoerfer RN, Wang N, Pallesen J, Wrapp D, Turner HL, Cottrell CA, Corbett KS, Graham BS, McLellan JS, Ward AB. Publisher Correction: Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis. Scientific Reports. 8: 17823. PMID 30531867 DOI: 10.1038/S41598-018-36918-8  1
2018 Rosen O, Chan LL, Abiona O, Gough P, Wang L, Shi W, Zhang Y, Wang N, Kong WP, McLellan JS, Graham BS, Corbett KS. A high-throughput inhibition assay to study MERS-CoV antibody interactions using image cytometry. Journal of Virological Methods. PMID 30468747 DOI: 10.1016/J.Jviromet.2018.11.009  1
2018 Houser KV, Yamshchikov GV, Bellamy AR, May J, Enama ME, Sarwar U, Larkin B, Bailer RT, Koup R, Paskel M, Subbarao K, Anderson E, Bernstein DI, Creech B, Keyserling H, ... Graham BS, et al. DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial. Plos One. 13: e0206837. PMID 30388160 DOI: 10.1371/Journal.Pone.0206837  1
2018 Kirchdoerfer RN, Wang N, Pallesen J, Wrapp D, Turner HL, Cottrell CA, Corbett KS, Graham BS, McLellan JS, Ward AB. Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis. Scientific Reports. 8: 15701. PMID 30356097 DOI: 10.1038/S41598-018-34171-7  1
2018 Morabito KM, Ruckwardt TJ, Bar-Haim E, Nair D, Moin SM, Redwood AJ, Price DA, Graham BS. Memory Inflation Drives Tissue-Resident Memory CD8 T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus. Frontiers in Immunology. 9: 1861. PMID 30154789 DOI: 10.3389/fimmu.2018.01861  1
2018 Ke Z, Dillard RS, Chirkova T, Leon F, Stobart CC, Hampton CM, Strauss JD, Rajan D, Rostad CA, Taylor JV, Yi H, Shah R, Jin M, Hartert TV, Peebles RS, Graham BS, et al. The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography. Viruses. 10. PMID 30127286 DOI: 10.3390/V10080446  1
2018 Mazur NI, Horsley N, Englund JA, Nederend M, Magaret A, Kumar A, Jacobino SR, Xander H, Khatry SK, LeClerq SC, Steinhoff MC, Tielsch JM, Katz J, Graham BS, Bont LJ, et al. Breast milk prefusion F IgG as a correlate of protection against respiratory syncytial virus acute respiratory illness. The Journal of Infectious Diseases. PMID 30107412 DOI: 10.1093/Infdis/Jiy477  1
2018 Mazur NI, Higgins D, Nunes MC, Melero JA, Langedijk AC, Horsley N, Buchholz UJ, Openshaw PJ, McLellan JS, Englund JA, Mejias A, Karron RA, Simões EA, Knezevic I, Ramilo O, ... Graham BS, et al. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. The Lancet. Infectious Diseases. PMID 29914800 DOI: 10.1016/S1473-3099(18)30292-5  1
2018 Yassine HM, McTamney PM, Boyington JC, Ruckwardt TJ, Crank MC, Smatti MK, Ledgerwood JE, Graham BS. Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera. Scientific Reports. 8: 8628. PMID 29872070 DOI: 10.1038/S41598-018-26538-7  1
2018 Graham BS, Mascola JR, Fauci AS. Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases. Jama. PMID 29566112 DOI: 10.1001/Jama.2018.0345  1
2018 Wang L, Shi W, Chappell JD, Joyce MG, Zhang Y, Kanekiyo M, Becker MM, van Doremalen N, Fischer R, Wang N, Corbett KS, Choe M, Mason RD, Van Galen JG, Zhou T, ... Graham BS, et al. Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV Spike to avoid neutralization escape. Journal of Virology. PMID 29514901 DOI: 10.1128/JVI.02002-17  1
2018 Georgiev IS, Joyce MG, Chen RE, Leung K, McKee K, Druz A, Van Galen JG, Kanekiyo M, Tsybovsky Y, Yang ES, Yang Y, Acharya P, Pancera M, Thomas PV, Wanninger T, ... Graham BS, et al. Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens. Acs Infectious Diseases. PMID 29451984 DOI: 10.1021/Acsinfecdis.7B00192  1
2018 Goodwin E, Gilman MSA, Wrapp D, Chen M, Ngwuta JO, Moin SM, Bai P, Sivasubramanian A, Connor RI, Wright PF, Graham BS, McLellan JS, Walker LM. Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation. Immunity. PMID 29396163 DOI: 10.1016/J.Immuni.2018.01.005  1
2018 Gaudinski MR, Coates EE, Houser KV, Chen GL, Yamshchikov G, Saunders JG, Holman LA, Gordon I, Plummer S, Hendel CS, Conan-Cibotti M, Lorenzo MG, Sitar S, Carlton K, Laurencot C, ... Graham BS, et al. Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. Plos Medicine. 15: e1002493. PMID 29364886 DOI: 10.1371/Journal.Pmed.1002493  1
2018 Fong Y, Shen X, Ashley VC, Deal A, Seaton KE, Yu C, Grant SP, Ferrari G, deCamp AC, Bailer RT, Koup RA, Montefiori D, Haynes BF, Sarzotti-Kelsoe M, Graham BS, et al. Vaccine-induced antibody responses modify the association between T-cell immune responses and HIV-1 infection risk in HVTN 505. The Journal of Infectious Diseases. PMID 29325070 DOI: 10.1093/Infdis/Jiy008  1
2018 Wang B, DeKosky BJ, Timm MR, Lee J, Normandin E, Misasi J, Kong R, McDaniel JR, Delidakis G, Leigh KE, Niezold T, Choi CW, Viox EG, Fahad A, Cagigi A, ... Graham BS, et al. Functional interrogation and mining of natively paired human VH:VL antibody repertoires. Nature Biotechnology. PMID 29309060 DOI: 10.1038/Nbt.4052  1
2018 Goo L, DeMaso CR, Pelc RS, Ledgerwood JE, Graham BS, Kuhn RJ, Pierson TC. The Zika virus envelope protein glycan loop regulates virion antigenicity. Virology. 515: 191-202. PMID 29304471 DOI: 10.1016/J.Virol.2017.12.032  1
2018 Graham BS, Sullivan NJ. Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic. Nature Immunology. 19: 20-28. PMID 29199281 DOI: 10.1038/S41590-017-0007-9  1
2018 Graham BS, Pinto CCdX. Semiparametrically efficient estimation of the average linear regression function National Bureau of Economic Research. DOI: 10.1920/Wp.Cem.2018.6218  1
2018 Graham BS. Identifying and Estimating Neighborhood Effects Journal of Economic Literature. 56: 450-500. DOI: 10.1257/Jel.20160854  0.01
2017 Morabito KM, Graham BS. Zika Virus Vaccine Development. The Journal of Infectious Diseases. 216: S957-S963. PMID 29267918 DOI: 10.1093/infdis/jix464  1
2017 DeZure AD, Coates EE, Hu Z, Yamshchikov GV, Zephir KL, Enama ME, Plummer SH, Gordon IJ, Kaltovich F, Andrews S, McDermott A, Crank MC, Koup RA, Schwartz RM, Bailer RT, ... Graham BS, et al. An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial. Npj Vaccines. 2: 15. PMID 29263871 DOI: 10.1038/s41541-017-0016-6  1
2017 Gilbert PB, Juraska M, deCamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, ... Graham BS, et al. Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials. Statistical Communications in Infectious Diseases. 9. PMID 29218117 DOI: 10.1515/Scid-2016-0001  1
2017 Gaudinski MR, Houser KV, Morabito KM, Hu Z, Yamshchikov G, Rothwell RS, Berkowitz N, Mendoza F, Saunders JG, Novik L, Hendel CS, Holman LA, Gordon IJ, Cox JH, Edupuganti S, ... Graham BS, et al. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials. Lancet (London, England). PMID 29217376 DOI: 10.1016/S0140-6736(17)33105-7  1
2017 Tian D, Battles MB, Moin SM, Chen M, Modjarrad K, Kumar A, Kanekiyo M, Graepel KW, Taher NM, Hotard AL, Moore ML, Zhao M, Zheng ZZ, Xia NS, McLellan JS, Graham BS, et al. Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein. Nature Communications. 8: 1877. PMID 29187732 DOI: 10.1038/S41467-017-01858-W  1
2017 Rossey I, Gilman MSA, Kabeche SC, Sedeyn K, Wrapp D, Kanekiyo M, Chen M, Mas V, Spitaels J, Melero JA, Graham BS, Schepens B, McLellan JS, Saelens X. Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. Nature Communications. 8: 16165. PMID 29184149 DOI: 10.1038/Ncomms16165  1
2017 deCamp AC, Rolland M, Edlefsen PT, Sanders-Buell E, Hall B, Magaret CA, Fiore-Gartland AJ, Juraska M, Carpp LN, Karuna ST, Bose M, LePore S, Miller S, O'Sullivan A, Poltavee K, ... Graham BS, et al. Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120. Plos One. 12: e0185959. PMID 29149197 DOI: 10.1371/Journal.Pone.0185959  1
2017 Mayer KH, Seaton KE, Huang Y, Grunenberg N, Isaacs A, Allen M, Ledgerwood JE, Frank I, Sobieszczyk ME, Baden LR, Rodriguez B, Van Tieu H, Tomaras GD, Deal A, Goodman D, ... Graham BS, et al. Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial. Plos Medicine. 14: e1002435. PMID 29136037 DOI: 10.1371/Journal.Pmed.1002435  1
2017 Sastry M, Zhang B, Chen M, Joyce MG, Kong WP, Chuang GY, Ko K, Kumar A, Silacci C, Thom M, Salazar AM, Corti D, Lanzavecchia A, Taylor G, Mascola JR, Graham BS, et al. Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus. Plos One. 12: e0186854. PMID 29073183 DOI: 10.1371/Journal.Pone.0186854  1
2017 Grifoni A, Pham J, Sidney J, O'Rourke PH, Paul S, Peters B, Martini SR, de Silva AD, Ricciardi MJ, Magnani DM, Silveira CGT, Maestri A, Costa PR, de-Oliveira-Pinto LM, de Azeredo EL, ... Graham BS, et al. Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans. Journal of Virology. PMID 28978707 DOI: 10.1128/Jvi.01469-17  1
2017 Shan C, Muruato AE, Jagger BW, Richner J, Nunes BTD, Medeiros DBA, Xie X, Nunes JGC, Morabito KM, Kong WP, Pierson TC, Barrett AD, Weaver SC, Rossi SL, Vasconcelos PFC, Graham BS, et al. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nature Communications. 8: 676. PMID 28939807 DOI: 10.1038/S41467-017-00737-8  1
2017 Liu X, Liang B, Ngwuta J, Liu X, Surman S, Lingemann M, Kwong PD, Graham BS, Collins PL, Munir S. Attenuated human parainfluenza virus type 1 (HPIV1) expressing the respiratory syncytial virus (RSV) fusion F glycoprotein from an added gene: effects of pre-fusion stabilization and packaging of RSV F. Journal of Virology. PMID 28835504 DOI: 10.1128/Jvi.01101-17  1
2017 Pallesen J, Wang N, Corbett KS, Wrapp D, Kirchdoerfer RN, Turner HL, Cottrell CA, Becker MM, Wang L, Shi W, Kong WP, Andres EL, Kettenbach AN, Denison MR, Chappell JD, Graham BS, et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proceedings of the National Academy of Sciences of the United States of America. PMID 28807998 DOI: 10.1073/Pnas.1707304114  1
2017 Han Q, Williams WB, Saunders KO, Seaton KE, Wiehe KJ, Vandergrift N, Von Holle T, Trama AM, Parks RJ, Luo K, Gurley TC, Kepler TB, Marshall DJ, Montefiori DC, Sutherland LL, ... Graham BS, et al. HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces Gp41 Antibody Immunodominance in Rhesus Macaques. Journal of Virology. PMID 28794027 DOI: 10.1128/Jvi.00923-17  1
2017 Andrews SF, Joyce MG, Chambers MJ, Gillespie RA, Kanekiyo M, Leung K, Yang ES, Tsybovsky Y, Wheatley AK, Crank MC, Boyington JC, Prabhakaran MS, Narpala SR, Chen X, Bailer RT, ... Graham BS, et al. Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans. Science Immunology. 2. PMID 28783708 DOI: 10.1126/Sciimmunol.Aan2676  1
2017 Andrews SF, Graham BS, Mascola JR, McDermott AB. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin Stem. Cold Spring Harbor Perspectives in Biology. PMID 28663207 DOI: 10.1101/Cshperspect.A029413  1
2017 Zhao M, Zheng ZZ, Chen M, Modjarrad K, Zhang W, Zhan LT, Cao JL, Sun YP, McLellan JS, Graham BS, Xia NS. Discovery of a Prefusion RSV F-Specific Monoclonal Antibody that Provides Greater in vivo Protection than the Murine Precursor of Palivizumab. Journal of Virology. PMID 28539438 DOI: 10.1128/Jvi.00176-17  1
2017 Leemans A, De Schryver M, Van der Gucht W, Heykers A, Pintelon I, Hotard AL, Moore ML, Melero JA, McLellan JS, Graham BS, Broadbent L, Power UF, Caljon G, Cos P, Maes L, et al. Antibody-induced internalization of the human respiratory syncytial virus fusion protein. Journal of Virology. PMID 28468888 DOI: 10.1128/Jvi.00184-17  1
2017 Ruckwardt TJ, Morabito KM, Bar-Haim E, Nair D, Graham BS. Neonatal mice possess two phenotypically and functionally distinct lung-migratory CD103(+) dendritic cell populations following respiratory infection. Mucosal Immunology. PMID 28378805 DOI: 10.1038/mi.2017.28  1
2017 Coates EE, Costner PJ, Nason MC, Herrin DM, Conant S, Herscovitch P, Sarwar UN, Holman L, Mitchell J, Yamshchikov G, Koup RA, Graham BS, Millo CM, Ledgerwood JE. Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses. Clinical Nuclear Medicine. PMID 28288041 DOI: 10.1097/Rlu.0000000000001603  1
2017 Lyke KE, Ishizuka AS, Berry AA, Chakravarty S, DeZure A, Enama ME, James ER, Billingsley PF, Gunasekera A, Manoj A, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, ... Graham BS, et al. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proceedings of the National Academy of Sciences of the United States of America. PMID 28223498 DOI: 10.1073/Pnas.1615324114  1
2017 Janes HE, Cohen KW, Frahm N, De Rosa SC, Sanchez B, Hural J, Magaret CA, Karuna S, Bentley C, Gottardo R, Finak G, Grove D, Shen M, Graham BS, Koup RA, et al. Higher T cell responses induced by DNA/rAd5 HIV-1 preventive vaccine are associated with lower HIV-1 infection risk in an efficacy trial. The Journal of Infectious Diseases. PMID 28199679 DOI: 10.1093/Infdis/Jix086  1
2017 Rossey I, Gilman MS, Kabeche SC, Sedeyn K, Wrapp D, Kanekiyo M, Chen M, Mas V, Spitaels J, Melero JA, Graham BS, Schepens B, McLellan JS, Saelens X. Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. Nature Communications. 8: 14158. PMID 28194013 DOI: 10.1038/Ncomms14158  1
2017 Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, Dowd KA, Sutherland LL, Scearce RM, Parks R, Wagner W, Granados A, Greenhouse J, Walker M, Willis E, ... Graham BS, et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. PMID 28151488 DOI: 10.1038/Nature21428  1
2017 Graham BS. An Econometric Model of Network Formation With Degree Heterogeneity Econometrica. 85: 1033-1063. DOI: 10.1920/Wp.Cem.2017.0817  0.01
2016 Schwarz B, Morabito KM, Ruckwardt TJ, Patterson DP, Avera J, Miettinen HM, Graham BS, Douglas T. Viruslike Particles Encapsidating Respiratory Syncytial Virus M and M2 Proteins Induce Robust T Cell Responses. Acs Biomaterials Science & Engineering. 2: 2324-2332. PMID 29367948 DOI: 10.1021/Acsbiomaterials.6B00532  1
2016 Gilman MS, Castellanos CA, Chen M, Ngwuta JO, Goodwin E, Moin SM, Mas V, Melero JA, Wright PF, Graham BS, McLellan JS, Walker LM. Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors. Science Immunology. 1. PMID 28111638 DOI: 10.1126/Sciimmunol.Aaj1879  1
2016 Stobart CC, Rostad CA, Ke Z, Dillard RS, Hampton CM, Strauss JD, Yi H, Hotard AL, Meng J, Pickles RJ, Sakamoto K, Lee S, Currier MG, Moin SM, Graham BS, et al. A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation. Nature Communications. 7: 13916. PMID 28000669 DOI: 10.1038/Ncomms13916  1
2016 Bar KJ, Sneller MC, Harrison LJ, Justement JS, Overton ET, Petrone ME, Salantes DB, Seamon CA, Scheinfeld B, Kwan RW, Learn GH, Proschan MA, Kreider EF, Blazkova J, Bardsley M, ... Graham BS, et al. Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption. The New England Journal of Medicine. 375: 2037-2050. PMID 27959728 DOI: 10.1056/Nejmoa1608243  1
2016 DeZure AD, Berkowitz NM, Graham BS, Ledgerwood JE. Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus. The Journal of Infectious Diseases. 214: S497-S499. PMID 27920180 DOI: 10.1093/Infdis/Jiw352  1
2016 Malloy AM, Ruckwardt TJ, Morabito KM, Lau-Kilby AW, Graham BS. Pulmonary Dendritic Cell Subsets Shape the Respiratory Syncytial Virus-Specific CD8+ T Cell Immunodominance Hierarchy in Neonates. Journal of Immunology (Baltimore, Md. : 1950). PMID 27895172 DOI: 10.4049/jimmunol.1600486  1
2016 Crank MC, Wilson EM, Novik L, Enama ME, Hendel CS, Gu W, Nason MC, Bailer RT, Nabel GJ, McDermott AB, Mascola JR, Koup RA, Ledgerwood JE, Graham BS. Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012). Plos One. 11: e0166393. PMID 27846256 DOI: 10.1371/Journal.Pone.0166393  1
2016 Gilchuk I, Gilchuk P, Sapparapu G, Lampley R, Singh V, Kose N, Blum DL, Hughes LJ, Satheshkumar PS, Townsend MB, Kondas AV, Reed Z, Weiner Z, Olson VA, Hammarlund E, ... Graham BS, et al. Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections. Cell. 167: 684-694.e9. PMID 27768891 DOI: 10.1016/J.Cell.2016.09.049  1
2016 Dowd KA, Ko SY, Morabito KM, Yang ES, Pelc RS, DeMaso CR, Castilho LR, Abbink P, Boyd M, Nityanandam R, Gordon DN, Gallagher JR, Chen X, Todd JP, Tsybovsky Y, ... Graham BS, et al. Rapid development of a DNA vaccine for Zika virus. Science (New York, N.Y.). PMID 27708058 DOI: 10.1126/Science.Aai9137  1
2016 Pierson TC, Graham BS. Zika Virus: Immunity and Vaccine Development. Cell. PMID 27693357 DOI: 10.1016/J.Cell.2016.09.020  1
2016 Goo L, Dowd KA, Lin TY, Mascola JR, Graham BS, Ledgerwood JE, Pierson TC. A virus-like particle vaccine elicits broad neutralizing antibody responses in humans to all Chikungunya virus genotypes. The Journal of Infectious Diseases. PMID 27655868 DOI: 10.1093/Infdis/Jiw431  1
2016 Francica JR, Lynn GM, Laga R, Joyce MG, Ruckwardt TJ, Moribito KM, Chen M, Chaudhuri R, Zhang B, Sastry M, Ko K, Choe M, Pechar M, Georgiev IS, Kueltzo LA, ... Graham BS, et al. Thermo-Responsive Polymer Nanoparticles Co-Deliver RSV F Trimers with a TLR-7/8 Adjuvant. Bioconjugate Chemistry. PMID 27583777 DOI: 10.1021/Acs.Bioconjchem.6B00370  1
2016 Roberts JN, Graham BS, Karron RA, Munoz FM, Falsey AR, Anderson LJ, Marshall V, Kim S, Beeler JA. Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop. Vaccine. PMID 27566900 DOI: 10.1016/J.Vaccine.2016.07.057  1
2016 Dowd KA, DeMaso CR, Pelc RS, Speer SD, Smith AR, Goo L, Platt DJ, Mascola JR, Graham BS, Mulligan MJ, Diamond MS, Ledgerwood JE, Pierson TC. Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype. Cell Reports. PMID 27481466 DOI: 10.1016/J.Celrep.2016.07.049  1
2016 Joyce MG, Zhang B, Ou L, Chen M, Chuang GY, Druz A, Kong WP, Lai YT, Rundlet EJ, Tsybovsky Y, Yang Y, Georgiev IS, Guttman M, Lees CR, Pancera M, ... Graham BS, et al. Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV. Nature Structural & Molecular Biology. PMID 27478931 DOI: 10.1038/Nsmb.3267  1
2016 Boyington JC, Joyce MG, Sastry M, Stewart-Jones GB, Chen M, Kong WP, Ngwuta JO, Thomas PV, Tsybovsky Y, Yang Y, Zhang B, Chen L, Druz A, Georgiev IS, Ko K, ... Graham BS, et al. Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus. Plos One. 11: e0159709. PMID 27463224 DOI: 10.1371/Journal.Pone.0159709  1
2016 Joyce MG, Wheatley AK, Thomas PV, Chuang GY, Soto C, Bailer RT, Druz A, Georgiev IS, Gillespie RA, Kanekiyo M, Kong WP, Leung K, Narpala SN, Prabhakaran MS, Yang ES, ... Graham BS, et al. Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses. Cell. PMID 27453470 DOI: 10.1016/J.Cell.2016.06.043  1
2016 Jacobino SR, Nederend M, Hennus M, Houben ML, Ngwuta JO, Viveen M, Coenjaerts FE, Hack CE, van Neerven RJ, Graham BS, Bont L, Leusen JH. Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection. The Journal of Allergy and Clinical Immunology. PMID 27448445 DOI: 10.1016/J.Jaci.2016.06.001  0.01
2016 Rostad CA, Stobart CC, Gilbert BE, Pickles RJ, Hotard AL, Meng J, Blanco JC, Moin SM, Graham BS, Piedra PA, Moore ML. A recombinant respiratory syncytial virus vaccine candidate attenuated by a low-fusion F protein is immunogenic and protective against challenge in cotton rats. Journal of Virology. PMID 27279612 DOI: 10.1128/Jvi.00012-16  0.01
2016 Ishizuka AS, Lyke KE, DeZure A, Berry AA, Richie TL, Mendoza FH, Enama ME, Gordon IJ, Chang LJ, Sarwar UN, Zephir KL, Holman LA, James ER, Billingsley PF, Gunasekera A, ... Graham BS, et al. Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nature Medicine. 22: 692. PMID 27270781 DOI: 10.1038/Nm0616-692C  1
2016 Morabito KM, Ruckwardt TR, Redwood AJ, Moin SM, Price DA, Graham BS. Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung. Mucosal Immunology. PMID 27220815 DOI: 10.1038/mi.2016.48  1
2016 Graham BS. Vaccines against respiratory syncytial virus: The time has finally come. Vaccine. PMID 27182820 DOI: 10.1016/J.Vaccine.2016.04.083  1
2016 Ishizuka AS, Lyke KE, DeZure A, Berry AA, Richie TL, Mendoza FH, Enama ME, Gordon IJ, Chang LJ, Sarwar UN, Zephir KL, Holman LA, James ER, Billingsley PF, Gunasekera A, ... Graham BS, et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nature Medicine. PMID 27158907 DOI: 10.1038/Nm.4110  1
2016 Hessell AJ, Jaworski JP, Epson E, Matsuda K, Pandey S, Kahl C, Reed J, Sutton WF, Hammond KB, Cheever TA, Barnette PT, Legasse AW, Planer S, Stanton JJ, Pegu A, ... ... Graham BS, et al. Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques. Nature Medicine. PMID 26998834 DOI: 10.1038/Nm.4063  1
2016 Ruckwardt TJ, Morabito KM, Graham BS. Determinants of early life immune responses to RSV infection. Current Opinion in Virology. 16: 151-157. PMID 26986236 DOI: 10.1016/j.coviro.2016.01.003  1
2016 Liu J, Haddad EK, Marceau J, Morabito KM, Rao SS, Filali-Mouhim A, Sekaly RP, Graham BS. A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited Immunopathology. Plos Pathogens. 12: e1005486. PMID 26943673 DOI: 10.1371/Journal.Ppat.1005486  1
2016 Kirchdoerfer RN, Cottrell CA, Wang N, Pallesen J, Yassine HM, Turner HL, Corbett KS, Graham BS, McLellan JS, Ward AB. Pre-fusion structure of a human coronavirus spike protein. Nature. 531: 118-21. PMID 26935699 DOI: 10.1038/Nature17200  1
2016 Corti D, Misasi J, Mulangu S, Stanley DA, Kanekiyo M, Wollen S, Ploquin A, Doria-Rose NA, Staupe RP, Bailey M, Shi W, Choe M, Marcus H, Thompson EA, Cagigi A, ... ... Graham BS, et al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science (New York, N.Y.). PMID 26917593 DOI: 10.1126/Science.Aad5224  1
2016 Misasi J, Gilman MS, Kanekiyo M, Gui M, Cagigi A, Mulangu S, Corti D, Ledgerwood JE, Lanzavecchia A, Cunningham J, Muyembe-Tamfun JJ, Baxa U, Graham BS, Xiang Y, Sullivan NJ, et al. Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science (New York, N.Y.). PMID 26917592 DOI: 10.1126/Science.Aad6117  1
2016 Morabito KM, Erez N, Graham BS, Ruckwardt TJ. Phenotype and Hierarchy of Two Transgenic T Cell Lines Targeting the Respiratory Syncytial Virus KdM282-90 Epitope Is Transfer Dose-Dependent. Plos One. 11: e0146781. PMID 26752171 DOI: 10.1371/Journal.Pone.0146781  1
2016 Graham BS, Knight GW, Graham L. Dental Student Academic Integrity in U.S. Dental Schools: Current Status and Recommendations for Enhancement. Journal of Dental Education. 80: 5-13. PMID 26729679  1
2016 Graham BS, Hahn J, Poirier A, Powell JL. A quantile correlated random coefficients panel data model Journal of Econometrics. 206: 305-335. DOI: 10.1920/Wp.Cem.2016.3414  1
2016 Graham BS, Imbens GW, Ridder G. Identification and Efficiency Bounds for the Average Match Function Under Conditionally Exogenous Matching Journal of Business & Economic Statistics. 38: 303-316. DOI: 10.1920/Wp.Cem.2016.1016  1
2016 Graham BS, Pinto CCdX, Egel D. Efficient Estimation of Data Combination Models by the Method of Auxiliary-to-Study Tilting (AST) Journal of Business and Economic Statistics. 34: 288-301. DOI: 10.1080/07350015.2015.1038544  1
2016 Giersing BK, Modjarrad K, Kaslow DC, Moorthy VS, Bavdekar A, Cichutek K, Cravioto A, Fritzell B, Graham BS, Karron R, Lanata CF, Powell M, Shao Y, Smith P. Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7-9th Sep 2015 Vaccine. 34: 2865-2869. DOI: 10.1016/J.Vaccine.2016.02.078  1
2016 DeZure A, Graham BS. Vaccines for Emerging Viral Diseases The Vaccine Book: Second Edition. 543-560. DOI: 10.1016/B978-0-12-802174-3.00028-X  1
2015 De Santis O, Audran R, Pothin E, Warpelin-Decrausaz L, Vallotton L, Wuerzner G, Cochet C, Estoppey D, Steiner-Monard V, Lonchampt S, Thierry AC, Mayor C, Bailer RT, Mbaya OT, Zhou Y, ... ... Graham BS, et al. Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study. The Lancet. Infectious Diseases. PMID 26725450 DOI: 10.1016/S1473-3099(15)00486-7  1
2015 Lynch RM, Boritz E, Coates EE, DeZure A, Madden P, Costner P, Enama ME, Plummer S, Holman L, Hendel CS, Gordon I, Casazza J, Conan-Cibotti M, Migueles SA, Tressler R, ... ... Graham BS, et al. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection. Science Translational Medicine. 7: 319ra206. PMID 26702094 DOI: 10.1126/Scitranslmed.Aad5752  1
2015 Fuchs JD, Bart PA, Frahm N, Morgan C, Gilbert PB, Kochar N, DeRosa SC, Tomaras GD, Wagner TM, Baden LR, Koblin BA, Rouphael NG, Kalams SA, Keefer MC, Goepfert PA, ... Graham BS, et al. Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals. Journal of Aids & Clinical Research. 6. PMID 26587311 DOI: 10.4172/2155-6113.1000461  1
2015 Tapia MD, Sow SO, Lyke KE, Haidara FC, Diallo F, Doumbia M, Traore A, Coulibaly F, Kodio M, Onwuchekwa U, Sztein MB, Wahid R, Campbell JD, Kieny MP, Moorthy V, ... Graham B, et al. Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial. The Lancet. Infectious Diseases. PMID 26546548 DOI: 10.1016/S1473-3099(15)00362-X  1
2015 Walsh SR, Moodie Z, Fiore-Gartland AJ, Morgan C, Wilck MB, Hammer SM, Buchbinder SP, Kalams SA, Goepfert PA, Mulligan MJ, Keefer MC, Baden LR, Swann EM, Grant S, Ahmed H, ... Graham BS, et al. Vaccination with heterologous HIV envelope sequences and heterologous adenovirus vectors increases T cell responses to conserved regions (HVTN 083). The Journal of Infectious Diseases. PMID 26475930 DOI: 10.1093/Infdis/Jiv496  1
2015 Ngwuta JO, Chen M, Modjarrad K, Joyce MG, Kanekiyo M, Kumar A, Yassine HM, Moin SM, Killikelly AM, Chuang GY, Druz A, Georgiev IS, Rundlet EJ, Sastry M, Stewart-Jones GB, ... Graham BS, et al. Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera. Science Translational Medicine. 7: 309ra162. PMID 26468324 DOI: 10.1126/Scitranslmed.Aac4241  1
2015 Huang Y, Follmann D, Nason M, Zhang L, Huang Y, Mehrotra DV, Moodie Z, Metch B, Janes H, Keefer MC, Churchyard G, Robb ML, Fast PE, Duerr A, McElrath MJ, ... Graham BS, et al. Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials. Plos One. 10: e0136626. PMID 26332672 DOI: 10.1371/Journal.Pone.0136626  1
2015 Ledgerwood JE, Coates EE, Yamshchikov G, Saunders JG, Holman L, Enama ME, DeZure A, Lynch R, Gordon I, Plummer S, Hendel CS, Pegu A, Conan-Cibotti M, Sitar S, Bailer RT, ... Graham BS, et al. Safety, Pharmacokinetics, and Neutralization of the Broadly Neutralizing HIV-1 Human Monoclonal Antibody VRC01 in Healthy Adults. Clinical and Experimental Immunology. PMID 26332605 DOI: 10.1111/Cei.12692  1
2015 Yassine HM, Boyington JC, McTamney PM, Wei CJ, Kanekiyo M, Kong WP, Gallagher JR, Wang L, Zhang Y, Joyce MG, Lingwood D, Moin SM, Andersen H, Okuno Y, Rao SS, ... Graham BS, et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nature Medicine. PMID 26301691 DOI: 10.1038/Nm.3927  1
2015 Ledgerwood JE, Sullivan NJ, Graham BS. Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report. The New England Journal of Medicine. 373: 776. PMID 26287857 DOI: 10.1056/NEJMc1505499  1
2015 Wang L, Shi W, Joyce MG, Modjarrad K, Zhang Y, Leung K, Lees CR, Zhou T, Yassine HM, Kanekiyo M, Yang ZY, Chen X, Becker MM, Freeman M, Vogel L, ... Graham BS, et al. Evaluation of candidate vaccine approaches for MERS-CoV. Nature Communications. 6: 7712. PMID 26218507 DOI: 10.1038/Ncomms8712  1
2015 Gilman MS, Moin SM, Mas V, Chen M, Patel NK, Kramer K, Zhu Q, Kabeche SC, Kumar A, Palomo C, Beaumont T, Baxa U, Ulbrandt ND, Melero JA, Graham BS, et al. Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein. Plos Pathogens. 11: e1005035. PMID 26161532 DOI: 10.1371/Journal.Ppat.1005035  1
2015 Liang B, Surman S, Amaro-Carambot E, Kabatova B, Mackow N, Lingemann M, Yang L, McLellan JS, Graham BS, Kwong PD, Schaap-Nutt A, Collins PL, Munir S. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Pre-fusion F Protein Expressed by a Vaccine Candidate. Journal of Virology. PMID 26157122 DOI: 10.1128/Jvi.01373-15  1
2015 Stewart-Jones GB, Thomas PV, Chen M, Druz A, Joyce MG, Kong WP, Sastry M, Soto C, Yang Y, Zhang B, Chen L, Chuang GY, Georgiev IS, McLellan JS, Srivatsan S, ... Graham BS, et al. A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus. Plos One. 10: e0128779. PMID 26098893 DOI: 10.1371/Journal.Pone.0128779  1
2015 Wheatley AK, Whittle JR, Lingwood D, Kanekiyo M, Yassine HM, Ma SS, Narpala SR, Prabhakaran MS, Matus-Nicodemos RA, Bailer RT, Nabel GJ, Graham BS, Ledgerwood JE, Koup RA, McDermott AB. H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem. Journal of Immunology (Baltimore, Md. : 1950). 195: 602-10. PMID 26078272 DOI: 10.4049/Jimmunol.1402835  1
2015 Graham BS, Modjarrad K, McLellan JS. Novel antigens for RSV vaccines. Current Opinion in Immunology. 35: 30-8. PMID 26070108 DOI: 10.1016/J.Coi.2015.04.005  1
2015 Ledgerwood JE, Bellamy AR, Belshe R, Bernstein DI, Edupuganti S, Patel SM, Renehan P, Zajdowicz T, Schwartz R, Koup R, Bailer RT, Yamshchikov GV, Enama ME, Sarwar U, Larkin B, Graham BS, et al. DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial. Plos One. 10: e0125914. PMID 25950433 DOI: 10.1371/Journal.Pone.0125914  1
2015 Crank MC, Gordon IJ, Yamshchikov GV, Sitar S, Hu Z, Enama ME, Holman LA, Bailer RT, Pearce MB, Koup RA, Mascola JR, Nabel GJ, Tumpey TM, Schwartz RM, Graham BS, et al. Phase 1 study of pandemic H1 DNA vaccine in healthy adults. Plos One. 10: e0123969. PMID 25884189 DOI: 10.1371/Journal.Pone.0123969  1
2015 Regules JA, Beigel JH, Paolino KM, Voell J, Castellano AR, Muñoz P, Moon JE, Ruck RC, Bennett JW, Twomey PS, Gutiérrez RL, Remich SA, Hack HR, Wisniewski ML, Josleyn MD, ... Graham BS, et al. A Recombinant Vesicular Stomatitis Virus Ebola Vaccine - Preliminary Report. The New England Journal of Medicine. PMID 25830322 DOI: 10.1056/Nejmoa1414216  1
2015 Kines RC, Zarnitsyn V, Johnson TR, Pang YY, Corbett KS, Nicewonger JD, Gangopadhyay A, Chen M, Liu J, Prausnitz MR, Schiller JT, Graham BS. Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles. Plos One. 10: e0120797. PMID 25785935 DOI: 10.1371/Journal.Pone.0120797  1
2015 Graham BS, Ambrosino DM. History of passive antibody administration for prevention and treatment of infectious diseases. Current Opinion in Hiv and Aids. 10: 129-34. PMID 25760933 DOI: 10.1097/Coh.0000000000000154  1
2015 Rampling T, Ewer K, Bowyer G, Wright D, Imoukhuede EB, Payne R, Hartnell F, Gibani M, Bliss C, Minhinnick A, Wilkie M, Venkatraman N, Poulton I, Lella N, Roberts R, ... Graham BS, et al. A Monovalent Chimpanzee Adenovirus Ebola Vaccine - Preliminary Report. The New England Journal of Medicine. PMID 25629663 DOI: 10.1056/Nejmoa1411627  1
2015 Kibuuka H, Berkowitz NM, Millard M, Enama ME, Tindikahwa A, Sekiziyivu AB, Costner P, Sitar S, Glover D, Hu Z, Joshi G, Stanley D, Kunchai M, Eller LA, Bailer RT, ... Graham BS, et al. Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial. Lancet (London, England). 385: 1545-54. PMID 25540891 DOI: 10.1016/S0140-6736(14)62385-0  1
2015 Sarwar UN, Costner P, Enama ME, Berkowitz N, Hu Z, Hendel CS, Sitar S, Plummer S, Mulangu S, Bailer RT, Koup RA, Mascola JR, Nabel GJ, Sullivan NJ, Graham BS, et al. Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial. The Journal of Infectious Diseases. 211: 549-57. PMID 25225676 DOI: 10.1093/Infdis/Jiu511  1
2015 Graham BS, Hahn J, Poirier A, Powell JL. Quantile Regression with Panel Data National Bureau of Economic Research. DOI: 10.1920/Wp.Cem.2015.1215  1
2015 Graham BS. Methods of Identification in Social Networks Annual Review of Economics. 7: 465-485. DOI: 10.1146/Annurev-Economics-080614-115611  1
2015 Williams WB, Liao HX, Moody MA, Kepler TB, Alam SM, Gao F, Wiehe K, Trama AM, Jones K, Zhang R, Song H, Marshall DJ, Whitesides JF, Sawatzki K, Hua A, ... Graham BS, et al. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies Science. 349. DOI: 10.1126/science.aab1253  1
2015 Sarwar U, Novik L, Enama M, Herrin D, Narpala S, Mcdermott A, Graham BS, Ledgerwood J. Early Innate and Adaptive Immune Responses to Investigational Human Immunodeficiency Virus (HIV)-1 Vaccines (VRC 016 study) Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.621  1
2015 Lorrain A, Graham BS, Popp BN, Allain V, Olson RJ, Hunt BPV, Potier M, Fry B, Galván-Magaña F, Menkes CER, Kaehler S, Ménard F. Nitrogen isotopic baselines and implications for estimating foraging habitat and trophic position of yellowfin tuna in the Indian and Pacific Oceans Deep-Sea Research Part Ii: Topical Studies in Oceanography. 113: 188-198. DOI: 10.1016/J.Dsr2.2014.02.003  1
2015 Kanekiyo M, Bu W, Joyce MG, Meng G, Whittle JRR, Baxa U, Yamamoto T, Narpala S, Todd JP, Rao SS, McDermott AB, Koup RA, Rossmann MG, Mascola JR, Graham BS, et al. Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site Cell. 162: 1090-1100. DOI: 10.1016/j.cell.2015.07.043  1
2015 Ledgerwood JE, Hu Z, Costner P, Yamshchikov G, Enama ME, Plummer S, Hendel CS, Holman L, Larkin B, Gordon I, Bailer RT, Poretz DM, Sarwar U, Kabadi A, Koup R, ... Graham BS, et al. Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost Contemporary Clinical Trials. 44: 112-118. DOI: 10.1016/j.cct.2015.08.006  1
2014 Herrin DM, Coates EE, Costner PJ, Kemp TJ, Nason MC, Saharia KK, Pan Y, Sarwar UN, Holman L, Yamshchikov G, Koup RA, Pang YY, Seder RA, Schiller JT, Graham BS, et al. Comparison of adaptive and innate immune responses induced by licensed vaccines for Human Papillomavirus. Human Vaccines & Immunotherapeutics. 10: 3446-54. PMID 25483691 DOI: 10.4161/Hv.34408  1
2014 Ledgerwood JE, DeZure AD, Stanley DA, Novik L, Enama ME, Berkowitz NM, Hu Z, Joshi G, Ploquin A, Sitar S, Gordon IJ, Plummer SA, Holman LA, Hendel CS, Yamshchikov G, ... Graham BS, et al. Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report. The New England Journal of Medicine. PMID 25426834 DOI: 10.1056/Nejmoa1410863  1
2014 Gordon SN, Doster MN, Kines RC, Keele BF, Brocca-Cofano E, Guan Y, Pegu P, Liyanage NP, Vaccari M, Cuburu N, Buck CB, Ferrari G, Montefiori D, Piatak M, Lifson JD, ... Graham BS, et al. Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia. Journal of Immunology (Baltimore, Md. : 1950). 193: 6172-83. PMID 25398324 DOI: 10.4049/Jimmunol.1401504  1
2014 Bart PA, Huang Y, Karuna ST, Chappuis S, Gaillard J, Kochar N, Shen X, Allen MA, Ding S, Hural J, Liao HX, Haynes BF, Graham BS, Gilbert PB, McElrath MJ, et al. HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial. The Journal of Clinical Investigation. 124: 4843-56. PMID 25271627 DOI: 10.1172/Jci75894  1
2014 Sarwar UN, Novik L, Enama ME, Plummer SA, Koup RA, Nason MC, Bailer RT, McDermott AB, Roederer M, Mascola JR, Ledgerwood JE, Graham BS. Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trial. Plos One. 9: e106240. PMID 25264782 DOI: 10.1371/Journal.Pone.0106240  1
2014 Rudicell RS, Kwon YD, Ko SY, Pegu A, Louder MK, Georgiev IS, Wu X, Zhu J, Boyington JC, Chen X, Shi W, Yang ZY, Doria-Rose NA, McKee K, O'Dell S, ... Graham BS, et al. Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo. Journal of Virology. 88: 12669-82. PMID 25142607 DOI: 10.1128/Jvi.02213-14  1
2014 Chang LJ, Dowd KA, Mendoza FH, Saunders JG, Sitar S, Plummer SH, Yamshchikov G, Sarwar UN, Hu Z, Enama ME, Bailer RT, Koup RA, Schwartz RM, Akahata W, Nabel GJ, ... Graham BS, et al. Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. Lancet. 384: 2046-52. PMID 25132507 DOI: 10.1016/S0140-6736(14)61185-5  1
2014 Bar-Haim E, Erez N, Malloy AM, Graham BS, Ruckwardt TJ. CD8+ TCR transgenic strains expressing public versus private TCR targeting the respiratory syncytial virus K(d)M2(82-90) epitope demonstrate similar functional profiles. Plos One. 9: e99249. PMID 24897427 DOI: 10.1371/Journal.Pone.0099249  1
2014 Manrique A, Adams E, Barouch DH, Fast P, Graham BS, Kim JH, Kublin JG, McCluskey M, Pantaleo G, Robinson HL, Russell N, Snow W, Johnston MI. The immune space: a concept and template for rationalizing vaccine development. Aids Research and Human Retroviruses. 30: 1017-22. PMID 24857015 DOI: 10.1089/Aid.2014.0040  1
2014 Kiss G, Holl JM, Williams GM, Alonas E, Vanover D, Lifland AW, Gudheti M, Guerrero-Ferreira RC, Nair V, Yi H, Graham BS, Santangelo PJ, Wright ER. Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex. Journal of Virology. 88: 7602-17. PMID 24760890 DOI: 10.1128/Jvi.00256-14  1
2014 Voronin Y, Mofenson LM, Cunningham CK, Fowler MG, Kaleebu P, McFarland EJ, Safrit JT, Graham BS, Snow W. HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission. Plos Medicine. 11: e1001616. PMID 24714363 DOI: 10.1371/Journal.Pmed.1001616  1
2014 Enama ME, Ledgerwood JE, Novik L, Nason MC, Gordon IJ, Holman L, Bailer RT, Roederer M, Koup RA, Mascola JR, Nabel GJ, Graham BS. Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (i.m.), subcutaneous (s.c.) and intradermal (i.d.) administration (VRC 011). Plos One. 9: e91366. PMID 24621858 DOI: 10.1371/Journal.Pone.0091366  1
2014 Ruckwardt TJ, Malloy AM, Morabito KM, Graham BS. Quantitative and qualitative deficits in neonatal lung-migratory dendritic cells impact the generation of the CD8+ T cell response. Plos Pathogens. 10: e1003934. PMID 24550729 DOI: 10.1371/journal.ppat.1003934  1
2014 Liu J, Cao S, Peppers G, Kim SH, Graham BS. Clonotype-specific avidity influences the dynamics and hierarchy of virus-specific regulatory and effector CD4(+) T-cell responses. European Journal of Immunology. 44: 1058-68. PMID 24510524 DOI: 10.1002/Eji.201343766  1
2014 Whittle JR, Wheatley AK, Wu L, Lingwood D, Kanekiyo M, Ma SS, Narpala SR, Yassine HM, Frank GM, Yewdell JW, Ledgerwood JE, Wei CJ, McDermott AB, Graham BS, Koup RA, et al. Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages. Journal of Virology. 88: 4047-57. PMID 24501410 DOI: 10.1128/Jvi.03422-13  1
2014 Correia BE, Bates JT, Loomis RJ, Baneyx G, Carrico C, Jardine JG, Rupert P, Correnti C, Kalyuzhniy O, Vittal V, Connell MJ, Stevens E, Schroeter A, Chen M, Macpherson S, ... Graham BS, et al. Proof of principle for epitope-focused vaccine design. Nature. 507: 201-6. PMID 24499818 DOI: 10.1038/Nature12966  1
2014 Johnson TR, Rangel D, Graham BS, Brough DE, Gall JG. Genetic vaccine for respiratory syncytial virus provides protection without disease potentiation. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 196-205. PMID 23752342 DOI: 10.1038/Mt.2013.142  1
2014 Graham BS, Imbens GW, Ridder G. Complementarity and aggregate implications of assortative matching: A nonparametric analysis Quantitative Economics. 5: 29-66. DOI: 10.3982/Qe45  1
2013 Graham BS, Anderson LJ. Challenges and opportunities for respiratory syncytial virus vaccines. Current Topics in Microbiology and Immunology. 372: 391-404. PMID 24362701 DOI: 10.1007/978-3-642-38919-1_20  1
2013 Collins PL, Fearns R, Graham BS. Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. Current Topics in Microbiology and Immunology. 372: 3-38. PMID 24362682 DOI: 10.1007/978-3-642-38919-1_1  1
2013 McLellan JS, Chen M, Joyce MG, Sastry M, Stewart-Jones GB, Yang Y, Zhang B, Chen L, Srivatsan S, Zheng A, Zhou T, Graepel KW, Kumar A, Moin S, Boyington JC, ... Graham BS, et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science (New York, N.Y.). 342: 592-8. PMID 24179220 DOI: 10.1126/Science.1243283  1
2013 Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD, Frahm N, Hural J, Anude C, Graham BS, Enama ME, et al. Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. The New England Journal of Medicine. 369: 2083-92. PMID 24099601 DOI: 10.1056/Nejmoa1310566  1
2013 Hillyer P, Raviv N, Gold DM, Dougherty D, Liu J, Johnson TR, Graham BS, Rabin RL. Subtypes of type I IFN differentially enhance cytokine expression by suboptimally stimulated CD4(+) T cells. European Journal of Immunology. 43: 3197-208. PMID 24030809 DOI: 10.1002/Eji.201243288  1
2013 Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, Richman A, Chakravarty S, Manoj A, Velmurugan S, Li M, ... Graham BS, et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science (New York, N.Y.). 341: 1359-65. PMID 23929949 DOI: 10.1126/Science.1241800  1
2013 Hertz T, Ahmed H, Friedrich DP, Casimiro DR, Self SG, Corey L, McElrath MJ, Buchbinder S, Horton H, Frahm N, Robertson MN, Graham BS, Gilbert P. HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1. Plos Pathogens. 9: e1003404. PMID 23818843 DOI: 10.1371/Journal.Ppat.1003404  1
2013 Ledgerwood JE, Zephir K, Hu Z, Wei CJ, Chang L, Enama ME, Hendel CS, Sitar S, Bailer RT, Koup RA, Mascola JR, Nabel GJ, Graham BS. Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect. The Journal of Infectious Diseases. 208: 418-22. PMID 23633407 DOI: 10.1093/Infdis/Jit180  1
2013 Khurana S, Wu J, Dimitrova M, King LR, Manischewitz J, Graham BS, Ledgerwood JE, Golding H. DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults. The Journal of Infectious Diseases. 208: 413-7. PMID 23633404 DOI: 10.1093/Infdis/Jit178  1
2013 McLellan JS, Chen M, Leung S, Graepel KW, Du X, Yang Y, Zhou T, Baxa U, Yasuda E, Beaumont T, Kumar A, Modjarrad K, Zheng Z, Zhao M, Xia N, ... Graham BS, et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science (New York, N.Y.). 340: 1113-7. PMID 23618766 DOI: 10.1126/Science.1234914  1
2013 Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS. Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine. 31: B209-15. PMID 23598484 DOI: 10.1016/J.Vaccine.2012.11.106  1
2013 Graham BS, Enama ME, Nason MC, Gordon IJ, Peel SA, Ledgerwood JE, Plummer SA, Mascola JR, Bailer RT, Roederer M, Koup RA, Nabel GJ. DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial. Plos One. 8: e59340. PMID 23577062 DOI: 10.1371/Journal.Pone.0059340  1
2013 Casazza JP, Bowman KA, Adzaku S, Smith EC, Enama ME, Bailer RT, Price DA, Gostick E, Gordon IJ, Ambrozak DR, Nason MC, Roederer M, Andrews CA, Maldarelli FM, Wiegand A, ... Graham BS, et al. Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire. The Journal of Infectious Diseases. 207: 1829-40. PMID 23482645 DOI: 10.1093/Infdis/Jit098  1
2013 Graham BS. Comparative static and computational methods for an empirical one-to-one transferable utility matching model Advances in Econometrics. 31: 153-181. DOI: 10.1108/S0731-9053(2013)0000032006  1
2013 Graham BS. Comment Journal of Business and Economic Statistics. 31: 266-270. DOI: 10.1080/07350015.2013.792261  1
2013 Chang L, Mendoza F, Saunders J, Plummer S, Yamshchikov GV, Ledgerwood JE, Graham BS. VRC 311: Phase I Clinical Trial of a Virus-Like Particle Chikungunya Vaccine in Healthy Adults The Journal of Allergy and Clinical Immunology. 131. DOI: 10.1016/J.Jaci.2012.12.1555  1
2013 Anderson LJ, Graham BS. Preface Current Topics in Microbiology and Immunology. 372: v-vii.  1
2012 Çuburu N, Graham BS, Buck CB, Kines RC, Pang YY, Day PM, Lowy DR, Schiller JT. Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses. The Journal of Clinical Investigation. 122: 4606-20. PMID 23143305 DOI: 10.1172/Jci63287  1
2012 Ledgerwood JE, Hu Z, Gordon IJ, Yamshchikov G, Enama ME, Plummer S, Bailer R, Pearce MB, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS. Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans. Clinical and Vaccine Immunology : Cvi. 19: 1792-7. PMID 22956656 DOI: 10.1128/Cvi.05663-11  1
2012 Gordon SN, Kines RC, Kutsyna G, Ma ZM, Hryniewicz A, Roberts JN, Fenizia C, Hidajat R, Brocca-Cofano E, Cuburu N, Buck CB, Bernardo ML, Robert-Guroff M, Miller CJ, Graham BS, et al. Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA. Journal of Immunology (Baltimore, Md. : 1950). 188: 714-23. PMID 22174446 DOI: 10.4049/Jimmunol.1101404  1
2012 Johnson TR, McLellan JS, Graham BS. Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2. Journal of Virology. 86: 1339-47. PMID 22090124 DOI: 10.1128/Jvi.06096-11  1
2012 Graham BS, Powell JL. Identification and estimation of average partial effects in "irregular" correlated random coefficient panel data models Econometrica. 80: 2105-2152. DOI: 10.3982/Ecta8220  1
2012 Graham BS, Campos De Xavier Pinto C, Egel D. Inverse probability tilting for moment condition models with missing data Review of Economic Studies. 79: 1053-1079. DOI: 10.1093/restud/rdr047  1
2011 Ruckwardt TJ, Malloy AM, Gostick E, Price DA, Dash P, McClaren JL, Thomas PG, Graham BS. Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice. Plos Pathogens. 7: e1002377. PMID 22144888 DOI: 10.1371/Journal.Ppat.1002377  1
2011 Graham BS. Future opportunities for passive immunity against viral diseases. The Journal of Infectious Diseases. 204: 1648-50. PMID 21998473 DOI: 10.1093/Infdis/Jir628  1
2011 Ledgerwood JE, Wei CJ, Hu Z, Gordon IJ, Enama ME, Hendel CS, McTamney PM, Pearce MB, Yassine HM, Boyington JC, Bailer R, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS, et al. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials. The Lancet. Infectious Diseases. 11: 916-24. PMID 21975270 DOI: 10.1016/S1473-3099(11)70240-7  1
2011 Baden LR, Blattner WA, Morgan C, Huang Y, Defawe OD, Sobieszczyk ME, Kochar N, Tomaras GD, McElrath MJ, Russell N, Brandariz K, Cardinali M, Graham BS, Barouch DH, Dolin R, et al. Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects. The Journal of Infectious Diseases. 204: 1541-9. PMID 21940420 DOI: 10.1093/Infdis/Jir615  1
2011 Koblin BA, Casapia M, Morgan C, Qin L, Wang ZM, Defawe OD, Baden L, Goepfert P, Tomaras GD, Montefiori DC, McElrath MJ, Saavedra L, Lau CY, Graham BS. Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial. Plos One. 6: e24517. PMID 21931737 DOI: 10.1371/Journal.Pone.0024517  1
2011 Judkowski V, Bunying A, Ge F, Appel JR, Law K, Sharma A, Raja-Gabaglia C, Norori P, Santos RG, Giulianotti MA, Slifka MK, Douek DC, Graham BS, Pinilla C. GM-CSF production allows the identification of immunoprevalent antigens recognized by human CD4+ T cells following smallpox vaccination. Plos One. 6: e24091. PMID 21931646 DOI: 10.1371/Journal.Pone.0024091  1
2011 Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, Moodie Z, Grove D, Gray G, Bekker LG, McElrath MJ, Tomaras GD, Goepfert P, Kalams S, Baden LR, Lally M, et al. A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204). Plos One. 6: e21225. PMID 21857901 DOI: 10.1371/Journal.Pone.0021225  1
2011 De Rosa SC, Thomas EP, Bui J, Huang Y, deCamp A, Morgan C, Kalams SA, Tomaras GD, Akondy R, Ahmed R, Lau CY, Graham BS, Nabel GJ, McElrath MJ. HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable. Journal of Immunology (Baltimore, Md. : 1950). 187: 3391-401. PMID 21844392 DOI: 10.4049/Jimmunol.1101421  1
2011 Li Y, O'Dell S, Walker LM, Wu X, Guenaga J, Feng Y, Schmidt SD, McKee K, Louder MK, Ledgerwood JE, Graham BS, Haynes BF, Burton DR, Wyatt RT, Mascola JR. Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01. Journal of Virology. 85: 8954-67. PMID 21715490 DOI: 10.1128/Jvi.00754-11  1
2011 McLellan JS, Yang Y, Graham BS, Kwong PD. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. Journal of Virology. 85: 7788-96. PMID 21613394 DOI: 10.1128/Jvi.00555-11  1
2011 McLellan JS, Correia BE, Chen M, Yang Y, Graham BS, Schief WR, Kwong PD. Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus. Journal of Molecular Biology. 409: 853-66. PMID 21549714 DOI: 10.1016/J.Jmb.2011.04.044  1
2011 Ledgerwood JE, Pierson TC, Hubka SA, Desai N, Rucker S, Gordon IJ, Enama ME, Nelson S, Nason M, Gu W, Bundrant N, Koup RA, Bailer RT, Mascola JR, Nabel GJ, Graham BS, et al. A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial. The Journal of Infectious Diseases. 203: 1396-404. PMID 21398392 DOI: 10.1093/Infdis/Jir054  1
2011 Johnson TR, Johnson CN, Corbett KS, Edwards GC, Graham BS. Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus. Plos One. 6: e16458. PMID 21297989 DOI: 10.1371/Journal.Pone.0016458  1
2011 Graham BS. Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Immunological Reviews. 239: 149-66. PMID 21198670 DOI: 10.1111/J.1600-065X.2010.00972.X  1
2011 Koup RA, Graham BS, Douek DC. The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors. Nature Reviews. Immunology. 11: 65-70. PMID 21164527 DOI: 10.1038/Nri2890  1
2011 Billam P, Bonaparte KL, Liu J, Ruckwardt TJ, Chen M, Ryder AB, Wang R, Dash P, Thomas PG, Graham BS. T Cell receptor clonotype influences epitope hierarchy in the CD8+ T cell response to respiratory syncytial virus infection. The Journal of Biological Chemistry. 286: 4829-41. PMID 21118816 DOI: 10.1074/Jbc.M110.191437  1
2011 Bethea DM, Carlson JK, Hollensead LD, Papastamatiou YP, Graham BS. A comparison of the foraging ecology and bioenergetics of the early life-stages of two sympatric hammerhead sharks Bulletin of Marine Science. 87: 873-889. DOI: 10.5343/Bms.2010.1047  1
2011 Graham BS. Efficiency Bounds for Missing Data Models With Semiparametric Restrictions Econometrica. 79: 437-452. DOI: 10.3982/Ecta7379  1
2011 Graham BS, Hirano K. Robustness to parametric assumptions in missing data models American Economic Review. 101: 538-543. DOI: 10.1257/Aer.101.3.538  1
2011 Graham BS, Crowe JE. Tribute to David T. Karzon, MD and Robert M. Chanock, MD Vaccine. 29: 3725-3727. DOI: 10.1016/J.Vaccine.2010.12.091  1
2011 Graham BS. Econometric methods for the analysis of assignment problems in the presence of complementarity and social spillovers Handbook of Social Economics. 1: 965-1052. DOI: 10.1016/B978-0-444-53707-2.00002-5  1
2010 Peiperl L, Morgan C, Moodie Z, Li H, Russell N, Graham BS, Tomaras GD, De Rosa SC, McElrath MJ. Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054). Plos One. 5: e13579. PMID 21048953 DOI: 10.1371/Journal.Pone.0013579  1
2010 Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, Koup RA, Roederer M, Bailer R, Mascola JR, Pau MG, ... Graham BS, et al. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine. 29: 304-13. PMID 21034824 DOI: 10.1016/J.Vaccine.2010.10.037  1
2010 McLellan JS, Chen M, Chang JS, Yang Y, Kim A, Graham BS, Kwong PD. Structure of a major antigenic site on the respiratory syncytial virus fusion glycoprotein in complex with neutralizing antibody 101F. Journal of Virology. 84: 12236-44. PMID 20881049 DOI: 10.1128/Jvi.01579-10  1
2010 Jaoko W, Karita E, Kayitenkore K, Omosa-Manyonyi G, Allen S, Than S, Adams EM, Graham BS, Koup RA, Bailer RT, Smith C, Dally L, Farah B, Anzala O, Muvunyi CM, et al. Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa. Plos One. 5: e12873. PMID 20877623 DOI: 10.1371/Journal.Pone.0012873  1
2010 Ruckwardt TJ, Luongo C, Malloy AM, Liu J, Chen M, Collins PL, Graham BS. Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope. Journal of Immunology (Baltimore, Md. : 1950). 185: 4673-80. PMID 20833834 DOI: 10.4049/Jimmunol.1001606  1
2010 Rimoin AW, Mulembakani PM, Johnston SC, Lloyd Smith JO, Kisalu NK, Kinkela TL, Blumberg S, Thomassen HA, Pike BL, Fair JN, Wolfe ND, Shongo RL, Graham BS, Formenty P, Okitolonda E, et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proceedings of the National Academy of Sciences of the United States of America. 107: 16262-7. PMID 20805472 DOI: 10.1073/Pnas.1005769107  1
2010 Chen M, Chang JS, Nason M, Rangel D, Gall JG, Graham BS, Ledgerwood JE. A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate. Journal of Immunological Methods. 362: 180-4. PMID 20727896 DOI: 10.1016/j.jim.2010.08.005  1
2010 Graham BS, McElrath MJ, Keefer MC, Rybczyk K, Berger D, Weinhold KJ, Ottinger J, Ferarri G, Montefiori DC, Stablein D, Smith C, Ginsberg R, Eldridge J, Duerr A, Fast P, et al. Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity. Plos One. 5: e11995. PMID 20706632 DOI: 10.1371/Journal.Pone.0011995  1
2010 Liu J, Ruckwardt TJ, Chen M, Nicewonger JD, Johnson TR, Graham BS. Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection. Journal of Virology. 84: 10501-9. PMID 20686045 DOI: 10.1128/Jvi.00963-10  1
2010 Graham BS, Kines RC, Corbett KS, Nicewonger J, Johnson TR, Chen M, LaVigne D, Roberts JN, Cuburu N, Schiller JT, Buck CB. Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination. Mucosal Immunology. 3: 475-86. PMID 20555315 DOI: 10.1038/Mi.2010.31  1
2010 Rosenberg ES, Graham BS, Chan ES, Bosch RJ, Stocker V, Maenza J, Markowitz M, Little S, Sax PE, Collier AC, Nabel G, Saindon S, Flynn T, Kuritzkes D, Barouch DH, et al. Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection. Plos One. 5: e10555. PMID 20479938 DOI: 10.1371/Journal.Pone.0010555  1
2010 Freel SA, Lamoreaux L, Chattopadhyay PK, Saunders K, Zarkowsky D, Overman RG, Ochsenbauer C, Edmonds TG, Kappes JC, Cunningham CK, Denny TN, Weinhold KJ, Ferrari G, Haynes BF, Koup RA, Graham BS, et al. Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination. Journal of Virology. 84: 4998-5006. PMID 20200250 DOI: 10.1128/Jvi.00138-10  1
2010 Koup RA, Roederer M, Lamoreaux L, Fischer J, Novik L, Nason MC, Larkin BD, Enama ME, Ledgerwood JE, Bailer RT, Mascola JR, Nabel GJ, Graham BS. Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses. Plos One. 5: e9015. PMID 20126394 DOI: 10.1371/Journal.Pone.0009015  1
2010 McLellan JS, Chen M, Kim A, Yang Y, Graham BS, Kwong PD. Structural basis of respiratory syncytial virus neutralization by motavizumab. Nature Structural & Molecular Biology. 17: 248-50. PMID 20098425 DOI: 10.1038/Nsmb.1723  1
2010 Kibuuka H, Kimutai R, Maboko L, Sawe F, Schunk MS, Kroidl A, Shaffer D, Eller LA, Kibaya R, Eller MA, Schindler KB, Schuetz A, Millard M, Kroll J, Dally L, ... Graham BS, et al. A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172). The Journal of Infectious Diseases. 201: 600-7. PMID 20078213 DOI: 10.1086/650299  1
2010 Cheng C, Gall JG, Nason M, King CR, Koup RA, Roederer M, McElrath MJ, Morgan CA, Churchyard G, Baden LR, Duerr AC, Keefer MC, Graham BS, Nabel GJ. Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization. Journal of Virology. 84: 630-8. PMID 19846512 DOI: 10.1128/Jvi.00866-09  1
2010 Olson RJ, Popp BN, Graham BS, López-Ibarra GA, Galván-Magaña F, Lennert-Cody CE, Bocanegra-Castillo N, Wallsgrove NJ, Gier E, Alatorre-Ramírez V, Ballance LT, Fry B. Food-web inferences of stable isotope spatial patterns in copepods and yellowfin tuna in the pelagic eastern Pacific Ocean Progress in Oceanography. 86: 124-138. DOI: 10.1016/j.pocean.2010.04.026  1
2010 Graham BS, Koch PL, Newsome SD, McMahon KW, Aurioles D. Using isoscapes to trace the movements and foraging behavior of top predators in oceanic ecosystems Isoscapes: Understanding Movement, Pattern, and Process On Earth Through Isotope Mapping. 299-318. DOI: 10.1007/978-90-481-3354-3_14  1
2009 Mohapatra S, Park SJ, Boyapalle S, Pastey MK, Graham BS, Blanck G. Human respiratory syncytial virus reduces the number of cells in S-phase and increases GADD153 expression in HEp-2 cells. Acta Virologica. 53: 207-11. PMID 19953728 DOI: 10.4149/AV_2009_03_207  1
2009 Graham BS. What does the report of the USMHRP Phase III study in Thailand mean for HIV and for vaccine developers? Clinical and Experimental Immunology. 158: 257-9. PMID 19906099 DOI: 10.1111/J.1365-2249.2009.04055.X  1
2009 Ledgerwood JE, Graham BS. DNA vaccines: a safe and efficient platform technology for responding to emerging infectious diseases. Human Vaccines. 5: 623-6. PMID 19779298 DOI: 10.4161/Hv.8627  1
2009 Graham BS, Ledgerwood JE, Nabel GJ. Vaccine development in the twenty-first century: Changing paradigms for elusive viruses Clinical Pharmacology and Therapeutics. 86: 234-236. PMID 19707212 DOI: 10.1038/Clpt.2009.128  1
2009 Johnson TR, Rao S, Seder RA, Chen M, Graham BS. TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity. Vaccine. 27: 3045-52. PMID 19428918 DOI: 10.1016/J.Vaccine.2009.03.026  1
2009 Sullivan NJ, Martin JE, Graham BS, Nabel GJ. Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule. Nature Reviews. Microbiology. 7: 393-400. PMID 19369954 DOI: 10.1038/Nrmicro2129  1
2009 Koup RA, Lamoreaux L, Zarkowsky D, Bailer RT, King CR, Gall JG, Brough DE, Graham BS, Roederer M. Replication-defective adenovirus vectors with multiple deletions do not induce measurable vector-specific T cells in human trials. Journal of Virology. 83: 6318-22. PMID 19339347 DOI: 10.1128/Jvi.00384-09  1
2009 Davis KL, Gray ES, Moore PL, Decker JM, Salomon A, Montefiori DC, Graham BS, Keefer MC, Pinter A, Morris L, Hahn BH, Shaw GM. High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination. Virology. 387: 414-26. PMID 19298995 DOI: 10.1016/J.Virol.2009.02.022  1
2009 Liu J, Ruckwardt TJ, Chen M, Johnson TR, Graham BS. Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model. Journal of Virology. 83: 4934-41. PMID 19264776 DOI: 10.1128/Jvi.02140-08  1
2009 Cecchini S, Negrete A, Virag T, Graham BS, Cohen JI, Kotin RM. Evidence of prior exposure to human bocavirus as determined by a retrospective serological study of 404 serum samples from adults in the United States. Clinical and Vaccine Immunology : Cvi. 16: 597-604. PMID 19244471 DOI: 10.1128/Cvi.00470-08  1
2009 Ruckwardt TJ, Bonaparte KL, Nason MC, Graham BS. Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. Journal of Virology. 83: 3019-28. PMID 19153229 DOI: 10.1128/Jvi.00036-09  1
2009 Hannides CCS, Popp BN, Landry MR, Graham BS. Quantification of zooplankton trophic position in the North Pacific Subtropical Gyre using stable nitrogen isotopes Limnology and Oceanography. 54: 50-61. DOI: 10.4319/Lo.2009.54.1.0050  1
2009 Casazza JP, Bowman K, Adzaku S, Ambrozak DA, Roederer M, Bailer RT, Enama M, Nason M, Ledgerwood JE, Graham BS, Koup RA. P18-06. Increased HIV-specific immunity in HIV-infected individuals vaccinated with a DNA prime, rAd5 boost regimen Retrovirology. 6: P315. DOI: 10.1186/1742-4690-6-S3-P315  1
2009 Sitar S, Hartman BI, Graham BS, Ledgerwood JE. P15-17. Social media as a tool for engaging and educating audiences around HIV vaccine research and clinical trial participation Retrovirology. 6: P218. DOI: 10.1186/1742-4690-6-S3-P218  1
2009 Enama ME, Novik L, Holman L, Gordon I, Nason M, Ledgerwood J, Graham BS. P14-12. Safety and tolerability of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular, subcutaneous and intradermal administration in healthy adults Retrovirology. 6: P200. DOI: 10.1186/1742-4690-6-S3-P200  1
2009 Ledgerwood JE, Novik L, Enama ME, Gordon IJ, Holman LA, Nason MC, Bailer RT, Roederer M, Koup RA, Mascola JR, Nabel GJ, Graham BS. P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011) Retrovirology. 6: P198. DOI: 10.1186/1742-4690-6-S3-P198  1
2009 Freel SA, Chattopadhyay PK, Lamoreaux L, Zarkowsky D, Overman RG, Ochsenbauer-Jambor C, Kappes JC, Cunningham CK, Denny TN, Weinhold KJ, Ferrari G, Koup RA, Graham BS, Haynes BF, Roederer M, et al. S01-04 OA. Phenotypic analyses of CD8+ T cells that mediate virus inhibition from HIV-1 vaccinees and HIV-1+ virus controllers Retrovirology. 6: O1. DOI: 10.1186/1742-4690-6-S3-O1  1
2009 Graham BS, Hahn J, Powell JL. The incidental parameter problem in a non-differentiable panel data model Economics Letters. 105: 181-182. DOI: 10.1016/J.Econlet.2009.07.015  1
2008 Martin JE, Louder MK, Holman LA, Gordon IJ, Enama ME, Larkin BD, Andrews CA, Vogel L, Koup RA, Roederer M, Bailer RT, Gomez PL, Nason M, Mascola JR, Nabel GJ, ... Graham BS, et al. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial. Vaccine. 26: 6338-43. PMID 18824060 DOI: 10.1016/J.Vaccine.2008.09.026  1
2008 Johnson TR, Rothenberg ME, Graham BS. Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein. Journal of Leukocyte Biology. 84: 748-59. PMID 18519743 DOI: 10.1189/Jlb.0907621  1
2008 Nelson S, Jost CA, Xu Q, Ess J, Martin JE, Oliphant T, Whitehead SS, Durbin AP, Graham BS, Diamond MS, Pierson TC. Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. Plos Pathogens. 4: e1000060. PMID 18464894 DOI: 10.1371/Journal.Ppat.1000060  1
2008 Shi W, Huang Y, Sutton-Smith M, Tissot B, Panico M, Morris HR, Dell A, Haslam SM, Boyington J, Graham BS, Yang ZY, Nabel GJ. A filovirus-unique region of Ebola virus nucleoprotein confers aberrant migration and mediates its incorporation into virions. Journal of Virology. 82: 6190-9. PMID 18417588 DOI: 10.1128/Jvi.02731-07  1
2008 Collins PL, Graham BS. Viral and host factors in human respiratory syncytial virus pathogenesis Journal of Virology. 82: 2040-2055. PMID 17928346 DOI: 10.1128/Jvi.01625-07  1
2008 Graham BS. Identifying social interactions through conditional cariance restrictions Econometrica. 76: 643-660. DOI: 10.1111/J.1468-0262.2008.00850.X  1
2008 Martin JE, Pierson TC, Graham BS. Reply to Rottinghaus and Poland Journal of Infectious Diseases. 197: 1628-1629. DOI: 10.1086/587945  1
2007 Martin JE, Pierson TC, Hubka S, Rucker S, Gordon IJ, Enama ME, Andrews CA, Xu Q, Davis BS, Nason M, Fay M, Koup RA, Roederer M, Bailer RT, Gomez PL, ... ... Graham BS, et al. A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial. The Journal of Infectious Diseases. 196: 1732-40. PMID 18190252 DOI: 10.1086/523650  1
2007 Eller MA, Eller LA, Opollo MS, Ouma BJ, Oballah PO, Galley L, Karnasuta C, Kim SR, Robb ML, Michael NL, Kibuuka H, Wabwire-Mangen F, Graham BS, Birx DL, de Souza MS, et al. Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans Vaccine. 25: 7737-7742. PMID 17920731 DOI: 10.1016/J.Vaccine.2007.08.056  1
2007 Graham BS. UIC is prepared for the future. Cds Review. 100: 6. PMID 17555010  1
2007 Precopio ML, Betts MR, Parrino J, Price DA, Gostick E, Ambrozak DR, Asher TE, Douek DC, Harari A, Pantaleo G, Bailer R, Graham BS, Roederer M, Koup RA. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. The Journal of Experimental Medicine. 204: 1405-16. PMID 17535971 DOI: 10.1084/Jem.20062363  1
2007 Catanzaro AT, Roederer M, Koup RA, Bailer RT, Enama ME, Nason MC, Martin JE, Rucker S, Andrews CA, Gomez PL, Mascola JR, Nabel GJ, Graham BS. Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine. Vaccine. 25: 4085-92. PMID 17391815 DOI: 10.1016/J.Vaccine.2007.02.050  1
2007 Tavel JA, Martin JE, Kelly GG, Enama ME, Shen JM, Gomez PL, Andrews CA, Koup RA, Bailer RT, Stein JA, Roederer M, Nabel GJ, Graham BS. Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 601-5. PMID 17325604 DOI: 10.1097/Qai.0B013E3180417Cb6  1
2007 Rutigliano JA, Ruckwardt TJ, Martin JE, Graham BS. Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection. Virology. 362: 314-9. PMID 17275872 DOI: 10.1016/J.Virol.2006.12.023  1
2007 Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. The histopathology of fatal untreated human respiratory syncytial virus infection. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 20: 108-19. PMID 17143259 DOI: 10.1038/Modpathol.3800725  1
2007 Parrino J, McCurdy LH, Larkin BD, Gordon IJ, Rucker SE, Enama ME, Koup RA, Roederer M, Bailer RT, Moodie Z, Gu L, Yan L, Graham BS. Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naïve and vaccinia-immune individuals Vaccine. 25: 1513-1525. PMID 17126963 DOI: 10.1016/J.Vaccine.2006.10.047  1
2007 Russell ND, Graham BS, Keefer MC, McElrath MJ, Self SG, Weinhold KJ, Montefiori DC, Ferrari G, Horton H, Tomaras GD, Gurunathan S, Baglyos L, Frey SE, Mulligan MJ, Harro CD, et al. Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 203-12. PMID 17106277 DOI: 10.1097/01.Qai.0000248356.48501.Ff  1
2007 Popp BN, Graham BS, Olson RJ, Hannides CCS, Lott MJ, López-Ibarra GA, Galván-Magaña F, Fry B. Insight into the Trophic Ecology of Yellowfin Tuna, Thunnus albacares, from Compound-Specific Nitrogen Isotope Analysis of Proteinaceous Amino Acids Terrestrial Ecology. 1: 173-190. DOI: 10.1016/S1936-7961(07)01012-3  1
2007 Graham BS, Grubbs D, Holland K, Popp BN. A rapid ontogenetic shift in the diet of juvenile yellowfin tuna from Hawaii Marine Biology. 150: 647-658. DOI: 10.1007/S00227-006-0360-Y  1
2006 Parrino J, Graham BS. Smallpox vaccines: Past, present, and future Journal of Allergy and Clinical Immunology. 118: 1320-1326. PMID 17157663 DOI: 10.1016/J.Jaci.2006.09.037  1
2006 Zhou W, Hashimoto K, Moore ML, Elias JA, Zhu Z, Durbin J, Colasurdo G, Rutigliano JA, Chiappetta CL, Goleniewska K, O'Neal JF, Graham BS, Peebles RS. IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse. Microbes and Infection / Institut Pasteur. 8: 2880-9. PMID 17110149 DOI: 10.1016/J.Micinf.2006.09.007  1
2006 Graham BS, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Martin JE, McCluskey MM, Chakrabarti BK, Lamoreaux L, Andrews CA, Gomez PL, Mascola JR, Nabel GJ. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. The Journal of Infectious Diseases. 194: 1650-60. PMID 17109336 DOI: 10.1086/509259  1
2006 Catanzaro AT, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Gu L, Martin JE, Novik L, Chakrabarti BK, Butman BT, Gall JG, King CR, Andrews CA, Sheets R, ... ... Graham BS, et al. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. The Journal of Infectious Diseases. 194: 1638-49. PMID 17109335 DOI: 10.1086/509258  1
2006 Graham BS. Educating dental students about oral health care access disparities. Journal of Dental Education. 70: 1208-11. PMID 17106036  1
2006 Smith EP, Hardaway CA, Graham BS, Johnstone PA. Folliculitis decalvans treated with radiation therapy. Cutis. 78: 162-4. PMID 17036658  1
2006 Khurana S, Needham J, Park S, Mathieson B, Busch MP, Nemo G, Nyambi P, Zolla-Pazner S, Laal S, Mulenga J, Chomba E, Hunter E, Allen S, McIntyre J, Hewlett I, ... ... Graham BS, et al. Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes. Journal of Acquired Immune Deficiency Syndromes (1999). 43: 304-12. PMID 17019363 DOI: 10.1097/01.Qai.0000242465.50947.5F  1
2006 Martin JE, Sullivan NJ, Enama ME, Gordon IJ, Roederer M, Koup RA, Bailer RT, Chakrabarti BK, Bailey MA, Gomez PL, Andrews CA, Moodie Z, Gu L, Stein JA, Nabel GJ, ... Graham BS, et al. A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial. Clinical and Vaccine Immunology : Cvi. 13: 1267-77. PMID 16988008 DOI: 10.1128/Cvi.00162-06  1
2006 Heraud JM, Edghill-Smith Y, Ayala V, Kalisz I, Parrino J, Kalyanaraman VS, Manischewitz J, King LR, Hryniewicz A, Trindade CJ, Hassett M, Tsai WP, Venzon D, Nalca A, Vaccari M, ... ... Graham BS, et al. Subunit recombinant vaccine protects against monkeypox Journal of Immunology. 177: 2552-2564. PMID 16888017 DOI: 10.4049/Jimmunol.177.4.2552  1
2006 Khurana S, Needham J, Mathieson B, Rodriguez-Chavez IR, Catanzaro AT, Bailer RT, Kim J, Polonis V, Cooper DA, Guerin J, Peterson ML, Gurwith M, Nguyen N, Graham BS, Golding H. Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies. Journal of Virology. 80: 2092-9. PMID 16474117 DOI: 10.1128/Jvi.80.5.2092-2099.2006  1
2006 Graham BS. New approaches to vaccine adjuvants: Inhibiting the inhibitor Plos Medicine. 3: 18-20. PMID 16383350 DOI: 10.1371/Journal.Pmed.0030057  1
2006 Graham BS, Temple JRW. Rich nations, poor nations: How much can multiple equilibria explain? Journal of Economic Growth. 11: 5-41. DOI: 10.1007/S10887-006-7404-5  1
2005 Peebles RS, Hashimoto K, Sheller JR, Moore ML, Morrow JD, Ji S, Elias JA, Goleniewska K, O'neal J, Mitchell DB, Graham BS, Zhou W. Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent. Journal of Immunology (Baltimore, Md. : 1950). 175: 8253-9. PMID 16339565 DOI: 10.1016/J.Jaci.2005.12.580  1
2005 Powell CL, Smith EP, Graham BS. Eruptive syringomas: an unusual presentation on the buttocks. Cutis. 76: 267-9. PMID 16315564  1
2005 Parlette EC, Elliott JZ, Hall FW, Graham BS. Primary cutaneous blastic natural killer cell lymphoma [6] Journal of the American Academy of Dermatology. 53: 742-743. PMID 16198814 DOI: 10.1016/j.jaad.2005.04.044  1
2005 Hashimoto K, Durbin JE, Zhou W, Collins RD, Ho SB, Kolls JK, Dubin PJ, Sheller JR, Goleniewska K, O'Neal JF, Olson SJ, Mitchell D, Graham BS, Peebles RS. Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. The Journal of Allergy and Clinical Immunology. 116: 550-7. PMID 16159623 DOI: 10.1016/J.Jaci.2005.03.051  1
2005 Graham BS. Dental education in crisis. Cds Review. 98: 6. PMID 16130310  1
2005 Peebles RS, Graham BS. Pathogenesis of respiratory syncytial virus infection in the murine model Proceedings of the American Thoracic Society. 2: 110-115. PMID 16113477 DOI: 10.1513/pats.200501-002AW  1
2005 Rutigliano JA, Rock MT, Johnson AK, Crowe JE, Graham BS. Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus. Virology. 337: 335-43. PMID 15916793 DOI: 10.1016/J.Virol.2005.04.032  1
2005 Del Rosario RN, Barr RJ, Graham BS, Kaneshiro S. Exogenous and endogenous cutaneous anomalies and curiosities American Journal of Dermatopathology. 27: 259-267. PMID 15900135 DOI: 10.1097/01.dad.0000158295.17792.dc  1
2005 O'Neill JT, Blair M, Graham BS. Necrotic ulcer on the thumb of a teenager with leukemia. Archives of Dermatology. 141: 633-8. PMID 15897391 DOI: 10.1001/archderm.141.5.633-g  1
2005 Gower TL, Pastey MK, Peeples ME, Collins PL, McCurdy LH, Hart TK, Guth A, Johnson TR, Graham BS. RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology. Journal of Virology. 79: 5326-36. PMID 15827147 DOI: 10.1128/Jvi.79.9.5326-5336.2005  1
2005 Graham BS, Mascola JR. Lessons from failure - Preparing for future HIV-1 vaccine efficacy trials Journal of Infectious Diseases. 191: 647-649. PMID 15688276 DOI: 10.1086/428406  1
2005 Hashimoto K, Sheller JR, Morrow JD, Collins RD, Goleniewska K, O'Neal J, Zhou W, Ji S, Mitchell DB, Graham BS, Peebles RS. Cyclooxygenase inhibition augments allergic inflammation through CD4-dependent, STAT6-independent mechanisms. Journal of Immunology (Baltimore, Md. : 1950). 174: 525-32. PMID 15611279 DOI: 10.4049/Jimmunol.174.1.525  1
2005 Graham BS, Hahn J. Identification and estimation of the linear-in-means model of social interactions Economics Letters. 88: 1-6. DOI: 10.1016/J.Econlet.2005.02.001  1
2004 Agwale SM, Tanimoto L, Womack C, Odama L, Leung K, Duey D, Negedu-Momoh R, Audu I, Mohammed SB, Inyang U, Graham B, Ziermann R. Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes Journal of Clinical Virology. 31: S3-S6. PMID 15567088 DOI: 10.1016/j.jcv.2004.09.001  1
2004 Schmidt AC, Johnson TR, Openshaw PJ, Braciale TJ, Falsey AR, Anderson LJ, Wertz GW, Groothuis JR, Prince GA, Melero JA, Graham BS. Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003. Virus Research. 106: 1-13. PMID 15522442 DOI: 10.1016/J.Virusres.2004.06.008  1
2004 McCurdy LH, Rutigliano JA, Johnson TR, Chen M, Graham BS. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4. Journal of Virology. 78: 12471-9. PMID 15507634 DOI: 10.1128/Jvi.78.22.12471-12479.2004  1
2004 Ku CC, Zerboni L, Ito H, Graham BS, Wallace M, Arvin AM. Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-α Journal of Experimental Medicine. 200: 917-925. PMID 15452178 DOI: 10.1084/jem.20040634  1
2004 Hashimoto K, Graham BS, Geraci MW, FitzGerald GA, Egan K, Zhou W, Goleniewska K, O'Neal JF, Morrow JD, Durbin RK, Wright PF, Collins RD, Suzutani T, Peebles RS. Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness. Journal of Virology. 78: 10303-9. PMID 15367596 DOI: 10.1128/Jvi.78.19.10303-10309.2004  1
2004 Rutigliano JA, Graham BS. Prolonged production of TNF-α exacerbates illness during respiratory syncytial virus infection Journal of Immunology. 173: 3408-3417. PMID 15322205 DOI: 10.4049/Jimmunol.173.5.3408  1
2004 Leach BC, Graham BS. Papular lesion of the proximal nail fold Archives of Dermatology. 140: 1003-1008. PMID 15313820  1
2004 Lee D, Graham BS, Chiu YL, Gilbert PB, McElrath MJ, Belshe RB, Buchbinder SP, Sheppard HW, Koblin BA, Mayer KH, Keefer MC, Mulligan MJ, Celum CL. Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160. The Journal of Infectious Diseases. 190: 903-7. PMID 15295694 DOI: 10.1086/423284  1
2004 Johnson TR, Varga SM, Braciale TJ, Graham BS. Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV. Journal of Virology. 78: 8753-60. PMID 15280483 DOI: 10.1128/Jvi.78.16.8753-8760.2004  1
2004 Budge PJ, Graham BS. Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses. The Journal of Antimicrobial Chemotherapy. 54: 299-302. PMID 15254023 DOI: 10.1093/Jac/Dkh355  1
2004 McCurdy LH, Larkin BD, Martin JE, Graham BS. Modified vaccinia Ankara: Potential as an alternative smallpox vaccine Clinical Infectious Diseases. 38: 1749-1753. PMID 15227622 DOI: 10.1086/421266  1
2004 Johnson TR, Teng MN, Collins PL, Graham BS. Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV. Journal of Virology. 78: 6024-32. PMID 15141000 DOI: 10.1128/Jvi.78.11.6024-6032.2004  1
2004 Hashimoto K, Graham BS, Ho SB, Adler KB, Collins RD, Olson SJ, Zhou W, Suzutani T, Jones PW, Goleniewska K, O'Neal JF, Peebles RS. Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5 American Journal of Respiratory and Critical Care Medicine. 170: 306-312. PMID 15130904 DOI: 10.1164/Rccm.200301-030Oc  1
2004 Budge PJ, Li Y, Beeler JA, Graham BS. RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G. Journal of Virology. 78: 5015-22. PMID 15113882 DOI: 10.1128/Jvi.78.10.5015-5022.2004  1
2004 Rutigliano JA, Johnson TR, Hollinger TN, Fischer JE, Aung S, Graham BS. Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection. Journal of Virology. 78: 3014-23. PMID 14990720 DOI: 10.1128/Jvi.78.6.3014-3023.2004  1
2004 Johnson TR, Graham BS. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection. The Pediatric Infectious Disease Journal. 23: S46-57. PMID 14730270 DOI: 10.1097/01.Inf.0000108192.94692.D2  1
2004 Peebles R, Mnich SJ, Goleniewska K, O'Neal JF, Mitchell D, Graham BS, Sheller JR. Systemic PGE2 neutralization results in enhanced allergic pulmonary inflammation in a murine model The Journal of Allergy and Clinical Immunology. 113. DOI: 10.1016/J.Jaci.2004.01.021  1
2003 Budge PJ, Lebowitz J, Graham BS. Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers. Antimicrobial Agents and Chemotherapy. 47: 3470-7. PMID 14576104 DOI: 10.1128/Aac.47.11.3470-3477.2003  1
2003 Tang YW, Johnson JE, Browning PJ, Cruz-Gervis RA, Davis A, Graham BS, Brigham KL, Oates JA, Loyd JE, Stecenko AA. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. Journal of Clinical Microbiology. 41: 2633-40. PMID 12791891 DOI: 10.1128/Jcm.41.6.2633-2640.2003  1
2003 Peebles RS, Hashimoto K, Graham BS. The complex relationship between respiratory syncytial virus and allergy in lung disease Viral Immunology. 16: 25-34. PMID 12725686 DOI: 10.1089/088282403763635429  1
2003 Johnson TR, Parker RA, Johnson JE, Graham BS. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge. Journal of Immunology (Baltimore, Md. : 1950). 170: 2037-45. PMID 12574374 DOI: 10.4049/Jimmunol.170.4.2037  1
2003 McCurdy LH, Graham BS. Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation Journal of Virology. 77: 1747-1756. PMID 12525608 DOI: 10.1128/Jvi.77.3.1747-1756.2003  1
2003 Bloom DE, Canning D, Graham B. Longevity and Life-cycle Savings* The Scandinavian Journal of Economics. 105: 319-338. DOI: 10.1111/1467-9442.T01-1-00001  0.01
2003 Peebles RS, Hashimoto K, Jones PW, Morrow JD, Collins RD, Goleniewska K, Furlong J, Mitchell DB, Graham BS, Sheller JR. Augmentation of allergic inflammation by cyclooxygenase (COX) inhibition does not depend on STAT6 signaling The Journal of Allergy and Clinical Immunology. 111. DOI: 10.1016/S0091-6749(03)81046-1  1
2002 Lee CG, Homer RJ, Cohn L, Link H, Jung S, Craft JE, Graham BS, Johnson TR, Elias JA. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. The Journal of Biological Chemistry. 277: 35466-74. PMID 12107190 DOI: 10.1074/Jbc.M206395200  1
2002 Graham BS, Rutigliano JA, Johnson TR. Respiratory syncytial virus immunobiology and pathogenesis. Virology. 297: 1-7. PMID 12083830 DOI: 10.1006/Viro.2002.1431  1
2002 Hashimoto K, Peebles RS, Sheller JR, Jarzecka K, Furlong J, Mitchell DB, Hartert TV, Graham BS. Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor. Thorax. 57: 524-7. PMID 12037228 DOI: 10.1136/Thorax.57.6.524  1
2002 Peebles RS, Hashimoto K, Morrow JD, Dworski R, Collins RD, Hashimoto Y, Christman JW, Kang KH, Jarzecka K, Furlong J, Mitchell DB, Talati M, Graham BS, Sheller JR. Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. American Journal of Respiratory and Critical Care Medicine. 165: 1154-60. PMID 11956061 DOI: 10.1164/Ajrccm.165.8.2106025  1
2002 Johnson TR, Hong S, Van Kaer L, Koezuka Y, Graham BS. NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus. Journal of Virology. 76: 4294-303. PMID 11932395 DOI: 10.1128/Jvi.76.9.4294-4303.2002  1
2002 Wright PF, Gruber WC, Peters M, Reed G, Zhu Y, Robinson F, Coleman-Dockery S, Graham BS. Illness Severity, Viral Shedding, and Antibody Responses in Infants Hospitalized with Bronchiolitis Caused by Respiratory Syncytial Virus The Journal of Infectious Diseases. 185: 1011-1018. PMID 11930309 DOI: 10.1086/339822  1
2002 Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS. The role of IFN in respiratory syncytial virus pathogenesis. Journal of Immunology (Baltimore, Md. : 1950). 168: 2944-52. PMID 11884466 DOI: 10.4049/Jimmunol.168.6.2944  1
2002 Graham BS. Clinical trials of HIV vaccines Annual Review of Medicine. 53: 207-221. PMID 11818471 DOI: 10.1146/Annurev.Med.53.082901.104035  1
2002 Bloom DE, Canning D, Graham BS. Longevity and Life Cycle Savings National Bureau of Economic Research. DOI: 10.3386/W8808  0.01
2002 Peebles S, Hashimoto K, Morrow JD, Collins R, Jarzecka K, Furlong J, Mitchell D, Graham BS, Sheller JR. Augmentation of allergic inflammation by cyclooxygenase inhibition is not dependent on IL-4 The Journal of Allergy and Clinical Immunology. 109. DOI: 10.1016/S0091-6749(02)81600-1  1
2001 Bredenberg HK, Graham BS. Hospitalization costs of respiratory syncytial virus infection [1] Pediatric Infectious Disease Journal. 20: 1100-1101. PMID 11734726 DOI: 10.1097/00006454-200111000-00026  1
2001 Peebles RS, Hashimoto K, Collins RD, Jarzecka K, Furlong J, Mitchell DB, Sheller JR, Graham BS. Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges. The Journal of Infectious Diseases. 184: 1374-9. PMID 11709778 DOI: 10.1086/324429  1
2001 Peebles RS, Graham BS. Viruses, dendritic cells and the lung Respiratory Research. 2: 245-249. PMID 11686890 DOI: 10.1186/Rr63  1
2001 Aung S, Rutigliano JA, Graham BS. Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease. Journal of Virology. 75: 9918-24. PMID 11559824 DOI: 10.1128/Jvi.75.20.9918-9924.2001  1
2001 Johnson TR, Fischer JE, Graham BS. Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine. The Journal of General Virology. 82: 2107-16. PMID 11514719 DOI: 10.1099/0022-1317-82-9-2107  1
2001 Gower TL, Peeples ME, Collins PL, Graham BS. RhoA is activated during respiratory syncytial virus infection. Virology. 283: 188-96. PMID 11336544 DOI: 10.1006/Viro.2001.0891  1
2001 Gower TL, Graham BS. Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro. Antimicrobial Agents and Chemotherapy. 45: 1231-7. PMID 11257039 DOI: 10.1128/Aac.45.4.1231-1237.2001  1
2001 Evans TG, McElrath MJ, Matthews T, Montefiori D, Weinhold K, Wolff M, Keefer MC, Kallas EG, Corey L, Gorse GJ, Belshe R, Graham BS, Spearman PW, Schwartz D, Mulligan MJ, et al. QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans. Vaccine. 19: 2080-91. PMID 11228380 DOI: 10.1016/S0264-410X(00)00415-1  1
2001 Corey L, Mulligan M, Goepfert P, Sabbaj S, Clements-Mann ML, Harrow C, Schwartz D, Dolin R, Evans T, Keefer M, Belshe R, Gorse G, Frey S, McElrath J, Graham B, et al. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 env, gag, and pro in combination with RGP120 Journal of Infectious Diseases. 183: 563-570. PMID 11170981 DOI: 10.1086/318523  1
2001 Peebles RS, Sheller JR, Collins RD, Jarzecka AK, Mitchell DB, Parker RA, Graham BS. Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice. Journal of Medical Virology. 63: 178-88. PMID 11170055 DOI: 10.1002/1096-9071(20000201)63:2<178::AID-JMV1013>3.0.CO;2-O  1
2000 Fischer JE, Johnson JE, Johnson TR, Graham BS. Pertussis toxin sensitization alters the pathogenesis of subsequent respiratory syncytial virus infection. The Journal of Infectious Diseases. 182: 1029-38. PMID 10979896 DOI: 10.1086/315806  1
2000 Graham BS, Johnson TR, Peebles RS. Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology. 48: 237-47. PMID 10960663 DOI: 10.1016/S0162-3109(00)00233-2  1
2000 Peebles RS, Sheller JR, Collins RD, Jarzecka K, Mitchell DB, Graham BS. Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV. The Journal of Infectious Diseases. 182: 671-7. PMID 10950758 DOI: 10.1086/315783  1
2000 Peebles RS, Dworski R, Collins RD, Jarzecka K, Mitchell DB, Graham BS, Sheller JR. Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice. American Journal of Respiratory and Critical Care Medicine. 162: 676-81. PMID 10934105 DOI: 10.1164/Ajrccm.162.2.9911063  1
2000 Aung S, Graham BS. IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo. Journal of Immunology (Baltimore, Md. : 1950). 164: 3487-93. PMID 10725701 DOI: 10.4049/Jimmunol.164.7.3487  1
2000 Pastey MK, Gower TL, Spearman PW, Crowe JE, Graham BS. A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3. Nature Medicine. 6: 35-40. PMID 10613821 DOI: 10.1038/71503  1
2000 Peebles RC, Sheller JR, Jarzecka AK, Mitchell DB, Graham BS. 867 RSV infection decreases type 2 cytokine concentrations during allergen sensitization, yet increases airway hyperresponsiveness in mice The Journal of Allergy and Clinical Immunology. 105. DOI: 10.1016/S0091-6749(00)91295-8  1
1999 Aung S, Tang YW, Graham BS. Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo. Journal of Virology. 73: 8944-9. PMID 10515999 DOI: 10.1128/Jvi.73.11.8944-8949.1999  1
1999 Johnson TR, Graham BS. Secreted respiratory syncytial virus G glycoprotein induces interleukin- 5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism Journal of Virology. 73: 8485-8495. PMID 10482601 DOI: 10.1128/Jvi.73.10.8485-8495.1999  1
1999 Fisher RG, Crowe JE, Johnson TR, Tang Y, Graham BS. Passive IgA Monoclonal Antibody Is No More Effective Than IgG at Protecting Mice from Mucosal Challenge with Respiratory Syncytial Virus The Journal of Infectious Diseases. 180: 1324-1327. PMID 10479165 DOI: 10.1086/315037  1
1999 Gicheru MM, Otsyula M, Spearman P, Graham BS, Miller CJ, Robinson HL, Haigwood NL, Montefiori DC. Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm) Journal of Medical Primatology. 28: 97-104. PMID 10475110 DOI: 10.1111/J.1600-0684.1999.Tb00257.X  1
1999 Pastey MK, Crowe JE, Graham BS. RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation Journal of Virology. 73: 7262-7270. PMID 10438814 DOI: 10.1128/Jvi.73.9.7262-7270.1999  1
1999 Fischer JE, Johnson TR, Peebles RS, Graham BS. Vaccination with pertussis toxin alters the antibody response to simultaneous respiratory syncytial virus challenge Journal of Infectious Diseases. 180: 714-719. PMID 10438359 DOI: 10.1086/314947  1
1999 Fisher RG, Johnson JE, Dillon SB, Parker RA, Graham BS. Prophylaxis with respiratory syncytial virus F-specific humanized monoclonal antibody delays and moderately suppresses the native antibody response but does not impair immunity to late rechallenge Journal of Infectious Diseases. 180: 708-713. PMID 10438358 DOI: 10.1086/314965  1
1999 Evans TG, Keefer MC, Weinhold KJ, Wolff M, Montefiori D, Gorse GJ, Graham BS, McElrath MJ, Clements-Mann ML, Mulligan MJ, Fast P, Walker MC, Excler JL, Duliege AM, Tartaglia J. A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers. The Journal of Infectious Diseases. 180: 290-8. PMID 10395842 DOI: 10.1086/314895  1
1999 Gorse GJ, Corey L, Patel GB, Mandava M, Hsieh RH, Matthews TJ, Walker MC, McElrath MJ, Berman PW, Eibl MM, Belshe RB. HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. Aids Research and Human Retroviruses. 15: 115-32. PMID 10029244 DOI: 10.1089/088922299311547  1
1999 Peebles RS, Sheller JR, Johnson JE, Mitchell DB, Graham BS. Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice. Journal of Medical Virology. 57: 186-92. PMID 9892406 DOI: 10.1002/(Sici)1096-9071(199902)57:2<186::Aid-Jmv17>3.0.Co;2-Q  1
1998 Graham BS. Science, medicine, and the future: Infection with HIV-1 British Medical Journal. 317: 1297-1301. PMID 9804721 DOI: 10.1136/Bmj.317.7168.1297  1
1998 Clements-Mann ML, Weinhold K, Matthews TJ, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Hsieh RH, Mestecky J, Zolla-Pazner S, Mascola J, Schwartz D, Siliciano R, Corey L, Wright PF, et al. Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. The Journal of Infectious Diseases. 177: 1230-46. PMID 9593008 DOI: 10.1086/515288  1
1998 Johnson TR, Johnson JE, Roberts SR, Wertz GW, Parker RA, Graham BS. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge Journal of Virology. 72: 2871-2880. PMID 9525607 DOI: 10.1128/Jvi.72.4.2871-2880.1998  1
1998 Graham BS, McElrath MJ, Connor RI, Schwartz DH, Gorse GJ, Keefer MC, Mulligan MJ, Matthews TJ, Wolinsky SM, Montefiori DC, Vermund SH, Lambert JS, Corey L, Belshe RB, Dolin R, et al. Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. The Journal of Infectious Diseases. 177: 310-9. PMID 9466516 DOI: 10.1086/514209  1
1998 Corey L, McElrath MJ, Weinhold K, Matthews T, Stablein D, Graham B, Keefer M, Schwartz D, Gorse G. Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group. The Journal of Infectious Diseases. 177: 301-9. PMID 9466515 DOI: 10.1086/514202  1
1998 Connor RI, Korber BTM, Graham BS, Hahn BH, Ho DD, Walker BD, Neumann AU, Vermund SH, Mestecky J, Jackson S, Fenamore E, Cao Y, Gao F, Kalams S, Kunstman KJ, et al. Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines Journal of Virology. 72: 1552-1576. PMID 9445059 DOI: 10.1128/Jvi.72.2.1552-1576.1998  1
1997 Fischer JE, Johnson JE, Kuli-Zade RK, Johnson TR, Aung S, Parker RA, Graham BS. Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus. Journal of Virology. 71: 8672-7. PMID 9343225 DOI: 10.1128/Jvi.71.11.8672-8677.1997  1
1997 Keefer MC, Wolff M, Gorse GJ, Graham BS, Corey L, Clements-Mann ML, Verani-Ketter N, Erb S, Smith CM, Belshe RB, Wagner LJ, McElrath MJ, Schwartz DH, Fast P. Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group. Aids Research and Human Retroviruses. 13: 1163-77. PMID 9310283 DOI: 10.1089/AID.1997.13.1163  1
1997 Tang YW, Neuzil KM, Fischer JE, Robinson FW, Parker RA, Graham BS. Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus Vaccine. 15: 597-602. PMID 9178456 DOI: 10.1016/S0264-410X(96)00214-9  1
1997 Neuzil KM, Johnson JE, Tang Y, Prieels J, Slaoui M, Gar N, Graham BS. Adjuvants influence the quantitative and qualitative immune response in BALBc mice immunized with respiratory syncytial virus FG subunit vaccine Vaccine. 15: 525-532. PMID 9160520 DOI: 10.1016/S0264-410X(97)00218-1  1
1997 Tang YW, Graham BS. T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice Journal of Clinical Investigation. 99: 2183-2191. PMID 9151790 DOI: 10.1172/Jci119391  1
1997 Neuzil KM, Gruber WC, Graham BS. Vitamin A therapy for respiratory syncytial virus infection [3] Pediatric Infectious Disease Journal. 16: 84-85. PMID 9002114 DOI: 10.1097/00006454-199701000-00024  1
1996 Graham BS. Immunological determinants of disease caused by respiratory syncytial virus Trends in Microbiology. 4: 290-294. PMID 8829339 DOI: 10.1016/0966-842X(96)10032-9  1
1996 Lindgren C, Lin J, Graham BS, Gray ME, Parker RA, Sundell HW. Respiratory syncytial virus infection enhances the response to laryngeal chemostimulation and inhibits arousal from sleep in young lambs. Acta Paediatrica (Oslo, Norway : 1992). 85: 789-97. PMID 8819543 DOI: 10.1111/j.1651-2227.1996.tb14153.x  1
1996 Keefer MC, Graham BS, McElrath MJ, Matthews TJ, Stablein DM, Corey L, Wright PF, Lawrence D, Fast PE, Weinhold K, Hsieh RH, Chernoff D, Dekker C, Dolin R. Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group. Aids Research and Human Retroviruses. 12: 683-93. PMID 8744579 DOI: 10.1089/Aid.1996.12.683  1
1996 Graham BS, Keefer MC, McElrath MJ, Gorse GJ, Schwartz DH, Weinhold K, Matthews TJ, Esterlitz JR, Sinangil F, Fast PE. Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group. Annals of Internal Medicine. 125: 270-9. PMID 8678389 DOI: 10.7326/0003-4819-125-4-199608150-00003  1
1996 Neuzil KM, Tang YW, Graham BS. Protective role of TNF-α in respiratory syncytial virus infection in vitro and in vivo American Journal of the Medical Sciences. 311: 201-204. PMID 8615393 DOI: 10.1097/00000441-199605000-00001  1
1996 Mascola JR, Snyder SW, Weislow OS, Belay SM, Belshe RB, Schwartz DH, Clements ML, Dolin R, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Walker MC, Wagner KF, McNeil JG, et al. Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. The Journal of Infectious Diseases. 173: 340-8. PMID 8568294 DOI: 10.1093/Infdis/173.2.340  1
1996 Tang YW, Graham BS. Potential for directing appropriate responses to vaccines by cytokine manipulation Clinical Immunotherapeutics. 5: 327-333. DOI: 10.1007/Bf03259330  1
1996 Neuzil KM, Graham BS. Cytokine release and innate immunity in respiratory viral infection Seminars in Virology. 7: 255-264. DOI: 10.1006/Smvy.1996.0032  1
1995 Graham BS, Tang YW, Gruber WC. Topical immunoprophylaxis of respiratory syncytial virus (rsv)-challenged mice with rsv-specific immune globulin Journal of Infectious Diseases. 171: 1468-1474. PMID 7769280 DOI: 10.1093/Infdis/171.6.1468  1
1995 Tang VW, Graham BS. Interleukin-12 treatment during immunization elicits a t helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity Journal of Infectious Diseases. 172: 734-738. PMID 7658066 DOI: 10.1093/Infdis/172.3.734  1
1995 Neuzil KM, Gruber WC, Chytil F, Stahlman MT, Graham BS. Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections. Antimicrobial Agents and Chemotherapy. 39: 1191-3. PMID 7625814 DOI: 10.1128/Aac.39.5.1191  1
1995 Graham BS, Wright PF. Candidate AIDS vaccines New England Journal of Medicine. 333: 1331-1339. PMID 7566026 DOI: 10.1056/Nejm199511163332007  1
1995 Graham BS. Pathogenesis of respiratory syncytial virus vaccine-augmented pathology American Journal of Respiratory and Critical Care Medicine. 152. PMID 7551416 DOI: 10.1164/Ajrccm/152.4_Pt_2.S63  1
1995 Walker MC, Fast PE, Graham BS, Belshe R, Dolin R. Phase I/II preventive vaccine trials: Conference summary Aids Research and Human Retroviruses. 11: 1279-1285. DOI: 10.1089/Aid.1995.11.1279  1
1994 Neuzil KM, Gruber WC, Chytil F, Stahlman MT, Engelhardt B, Graham BS. Serum vitamin A levels in respiratory syncytial virus infection. The Journal of Pediatrics. 124: 433-6. PMID 8120715 DOI: 10.1016/S0022-3476(94)70369-8  1
1994 Belshe RB, Clements ML, Keefer MC, Graham BS, Corey L, Sposto R, Wescott S, Lawrence D. Interpreting HIV serodiagnostic test results in the 1990s: Social risks of HIV vaccine studies in uninfected volunteers Annals of Internal Medicine. 121: 584-589. PMID 8085690 DOI: 10.7326/0003-4819-121-8-199410150-00005  1
1994 Montefiori DC, Graham BS, Zhou JY, Zhou JT, Ahearn JM. Binding of human immunodeficiency virus type i to the c3b/c4b receptor crt (cd35) and red blood cells in the presence of envelope-specific antibodies and complement Journal of Infectious Diseases. 170: 429-432. PMID 8035031 DOI: 10.1093/infdis/170.2.429  1
1994 Tang YW, Graham BS. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus Journal of Clinical Investigation. 94: 1953-1958. PMID 7962541 DOI: 10.1172/Jci117546  1
1994 Gorse GJ, Schwartz DH, Graham BS, Matthews TJ, Stablein DM, Frey SE, Belshe RB, Clements ML, Wright PF, Eibl M. HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network. Clinical and Experimental Immunology. 98: 178-84. PMID 7955519 DOI: 10.1111/J.1365-2249.1994.Tb06122.X  1
1994 Graham BS, Gorse GJ, Schwartz DH, Keefer MC, McElrath MJ, Matthews TJ, Wright PF, Belshe RB, Clements ML, Dolin R. Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network. The Journal of Infectious Diseases. 170: 782-6. PMID 7930718 DOI: 10.1093/infdis/170.4.782  1
1994 Belshe RB, Gorse GJ, Graham BS, Wright P, Keefer MC, Dolin R, Matthews T, Weinhold K, Bolognesi DP, Sposto R, Stablein DM, Twaddell T, Berman PW, Gregory T, Izu AE, et al. Neutralizing Antibodies to HIV-1 in Seronegative Volunteers Immunized With Recombinant gp 120 From the MN Strain of HIV-1 Jama: the Journal of the American Medical Association. 272: 475-480. PMID 7913731 DOI: 10.1001/JAMA.272.6.475  1
1994 Keefer MC, Graham BS, Belshe RB, Schwartz D, Corey L, Bolognesi DP, Stablein DM, Montefiori DC, McElrath MJ, Clements ML. Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network. Aids Research and Human Retroviruses. 10: 1713-23. PMID 7888231 DOI: 10.1089/Aid.1994.10.1713  1
1994 Neuzil KM, Gruber WC, Chytil F, Stahlman MT, Graham BS. Reply to: Vitamin A for varicella The Journal of Pediatrics. 125: 1018. DOI: 10.1016/S0022-3476(05)82037-2  1
1993 Hesselton RM, Koup RA, Cromwell MA, Graham BS, Johns M, Sullivan JL. Human Peripheral Blood Xenografts in the SCID Mouse: Characterization of Immunologic Reconstitution Journal of Infectious Diseases. 168: 630-640. PMID 8354904 DOI: 10.1093/Infdis/168.3.630  1
1993 Montefiori DC, Graham BS, Zhou J, Zhou J, Bucco RA, Schwartz DH, Cavacini LA, Posner MR. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network. The Journal of Clinical Investigation. 92: 840-7. PMID 8349820 DOI: 10.1172/Jci116658  1
1993 Belshe RB, Clements ML, Dolin R, Graham BS, McElrath J, Gorse GJ, Schwartz D, Keefer MC, Wright P, Corey L, Bolognesi DP, Matthews TJ, Stablein DM, Brien FSO, Eibl M, et al. Safety and Immunogenicity of a Fully Glycosylated Recombinant gp160 Human Immunodeficiency Virus Type 1 Vaccine in Subjects at Low Risk of Infection Journal of Infectious Diseases. 168: 1387-1395. PMID 8245523 DOI: 10.1093/Infdis/168.6.1387  1
1993 Graham BS, Davis TH, Tang YW, Gruber WC. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum. Pediatric Research. 34: 167-72. PMID 8233720 DOI: 10.1203/00006450-199308000-00013  1
1993 Graham BS, Matthews TJ, Belshe RB, Clements ML, Dolin R, Wright PF, Gorse GJ, Schwartz DH, Keefer MC, Bolognesi DP. Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. The Journal of Infectious Diseases. 167: 533-7. PMID 8095059 DOI: 10.1093/infdis/167.3.533  1
1992 Lindgren C, Jing L, Graham B, Grögaard J, Sundell H. Respiratory syncytial virus infection reinforces reflex apnea in young lambs. Pediatric Research. 31: 381-5. PMID 1570205 DOI: 10.1203/00006450-199204000-00015  1
1992 Ukwu HN, Graham BS, Lambert JS, Wright PF. Perinatal transmission of human immunodeficiency virus-1 infection and maternal immunization strategies for prevention Obstetrics and Gynecology. 80: 458-468. PMID 1495707 DOI: 10.1016/0020-7292(93)90725-C  1
1992 Graham BS. Clinical trials of AIDS vaccines in seronegative volunteers: Vectors and combinations Aids Research and Human Retroviruses. 8: 1327-1328. PMID 1466951 DOI: 10.1089/Aid.1992.8.1327  1
1992 Ukwu HN, Graham BS, Latham RH. Acute pubic osteomyelitis in athletes Clinical Infectious Diseases. 15: 636-638. PMID 1420676 DOI: 10.1093/Clind/15.4.636  1
1992 Graham BS, Belshe RB, Clements ML, Dolin R, Corey L, Wright PF, Gorse GJ, Midthun K, Keefer MC, Roberts NJ, Schwartz DH, Agosti JM, Fernie BF, Stablein DM, Montefiori DC, et al. Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial Journal of Infectious Diseases. 166: 244-252. PMID 1353102 DOI: 10.1093/Infdis/166.2.244  1
1992 Montefiori DC, Graham BS, Kliks S, Wright PF. Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160 Journal of Clinical Immunology. 12: 429-439. PMID 1287035 DOI: 10.1007/Bf00918855  1
1991 Dolin R, Graham BS, Greenberg SB, Tacket CO, Belshe RB, Midthun K, Clements ML, Gorse GJ, Horgan BW, Atmar RL, Karzon DT, Bonnez W, Fernie BF, Montefiori DC, Stablein DM, et al. The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans Annals of Internal Medicine. 114: 119-127. PMID 1984386 DOI: 10.7326/0003-4819-114-2-119  1
1991 Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice Journal of Clinical Investigation. 88: 1026-1033. PMID 1909350 DOI: 10.1172/Jci115362  1
1991 Graham BS, Bunton LA, Rowland J, Wright PF, Karzon DT. Respiratory syncytial virus infection in anti-μ-treated mice Journal of Virology. 65: 4936-4942. PMID 1908028 DOI: 10.1128/Jvi.65.9.4936-4942.1991  1
1991 Graham BS, Bunton LA, Wright PF, Karzon DT. Reinfection of mice with respiratory syncytial virus Journal of Medical Virology. 34: 7-13. PMID 1885946 DOI: 10.1002/Jmv.1890340103  1
1990 Graham BS, Rowland JM, Modliszewski A, Montefiori DC. Antifusion activity in sera from persons infected with human immunodeficiency virus type 1. Journal of Clinical Microbiology. 28: 2608-11. PMID 2279989 DOI: 10.1128/Jcm.28.12.2608-2611.1990  1
1988 Hendry RM, Burns JC, Walsh EE, Graham BS, Wright PF, Hemming VG, Rodriguez WJ, Kim HW, Prince GA, McIntosh K, Chanock RM, Murphy BR. Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus Journal of Infectious Diseases. 157: 640-647. PMID 3346563 DOI: 10.1093/Infdis/157.4.640  1
1988 Graham BS, Perkins MD, Wright PF, Karzon DT. Primary respiratory syncytial virus infection in mice Journal of Medical Virology. 26: 153-162. PMID 3183639 DOI: 10.1002/Jmv.1890260207  1
1986 Wagner DK, Graham BS, Wright PF, Walsh EE, Kim HW, Reimer CB, Nelson DL, Chanock RM, Murphy BR. Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection. Journal of Clinical Microbiology. 24: 304-6. PMID 3755731 DOI: 10.1128/Jcm.24.2.304-306.1986  1
1986 Murphy BR, Graham BS, Prince GA, Walsh EE, Chanock RM, Karzon DT, Wright PF. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. Journal of Clinical Microbiology. 23: 1009-14. PMID 3754878 DOI: 10.1128/Jcm.23.6.1009-1014.1986  1
1984 Graham BS, Tucker WS. Opportunistic infections in endogenous Cushing's syndrome Annals of Internal Medicine. 101: 334-338. PMID 6331781 DOI: 10.7326/0003-4819-101-3-334  1
1984 Graham BS. Detection of bacteremia and fungemia: Microscopic examination of peripheral blood smears Infection Control. 5: 448-452. PMID 6208161 DOI: 10.1017/S0195941700060744  1
1983 Graham BS, Snell JD. Herpes simplex virus infection of the adult lower respiratory tract Medicine (United States). 62: 384-393. PMID 6355756 DOI: 10.1097/00005792-198311000-00004  1
Show low-probability matches.